Cardiomyopathy

I9_CARDMYO

cardiomyopathy: A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I42 Cause of death: ICD-10 — I42 2 out of 7 registries used, show all original rules.	7798
4. Check minimum number of events None	7798
5. Include endpoints I9_CARDMPRI I9_CARDMSEC I9_CARDMYOHYP I9_CARDMYOALC I9_CARDMYORESTR I9_CARDMYOOTH I9_CARDMYOINOTH	8223
6. Filter based on genotype QC (FinnGen only)	8015

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: I30-I52
Name in latin: Cardiomyopathia

NAME	I9_CARDMYO
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	I9_CARDMPRI\|I9_CARDMSEC\|I9_CARDMYOHYP\|I9_CARDMYOALC\|I9_CARDMYORESTR\|I9_CARDMYOOTH\|I9_CARDMYOINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I42
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I42
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cardiomyopathy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	64595	19959	43679
Only index persons	45919	15193	30726
Unadjusted period prevalence (%)
Whole population	1.02	0.57	1.22
Only index persons	0.97	0.56	1.17
Median age at first event (years)
Whole population	61.32	64.86	59.69
Only index persons	61.74	64.65	60.30

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8015	2682	5333
Unadjusted period prevalence (%)	1.94	0.95	2.44
Median age at first event (years)	61.80	61.66	61.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8222: Matched controls
82212

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TPH07

NOMESCO Finland

Cathetrisation of artery

3.4

323.3

1351

4498

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

3090.9

320.6

308

A12BA01

ATC

potassium chloride; oral

6.1

320.5

582

1015

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

811.8

319.9

313

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

4.2

312.9

899

2317

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

1600.9

311.1

301

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

398.4

309.0

309

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

170.3

307.7

963

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

17.7

307.7

367

216

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

188.1

307.7

428

C03CA01

ATC

furosemide; systemic

13.6

307.7

5502

10625

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

98.1

307.7

275

K77

ICPC

Heart failure

45.5

307.7

529

124

I44.2

ICD-10 Finland

Atrioventricular block, complete

5794.4

307.7

552

I42.0

ICD-10 Finland

Dilated cardiomyopathy

4503599627370496.0

307.7

4909

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

458.2

307.7

1903

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

88.1

307.7

223

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

272.7

307.7

439

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.1

307.7

2434

6289

C09DX04

ATC

valsartan and sacubitril; oral

4757.1

307.7

875

XF640, ,

NOMESCO Finland

15.9

307.7

497

332

C01BC04

ATC

flecainide; systemic

90.5

307.7

322

C03DA01

ATC

spironolactone; oral

24.8

307.7

3861

2835

C01BD01

ATC

amiodarone; systemic

481.2

307.7

1158

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.5

307.7

2748

10248

TFP34

NOMESCO Finland

Electrophysiological investigation

447.3

307.7

504

XF400

NOMESCO Finland

ECG with 12 standard connections

4.2

307.7

2119

6285

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

3437.2

307.7

1224

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

175.2

307.7

919

A10BK01

ATC

dapagliflozin; oral

4.8

307.7

1115

2625

I50.9

ICD-10 Finland

Heart failure, unspecified

247.2

307.7

4165

340

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

628.8

307.7

1493

207

Kela drug reimbursment

Chronic arrhythmias

600.7

307.7

2962

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.7

307.7

4991

24092

AN1

Coronary angiography

8.3

307.7

2307

3674

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

886.7

307.7

2391

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

518.6

307.7

2366

I50

ICD-10 Finland

Heart failure

55.5

307.7

739

146

I49.3

ICD-10 Finland

Ventricular premature depolarization

17.1

307.7

875

569

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

11.4

307.7

1627

1743

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

759.2

307.7

567

GD1LA

NOMESCO Finland

154.2

307.7

574

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

11.2

307.7

4657

8554

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

7188.2

307.7

672

K78

ICPC

Atrial fibrillation/flutter

33.6

307.7

1146

394

WX892

NOMESCO Finland

Monitored bed care

5.7

307.7

1158

2307

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.2

307.7

883

1871

I42.8

ICD-10 Finland

Other cardiomyopathies

4007.3

307.7

752

AP1

Catheterization of the left side of the heart

16.0

307.7

399

261

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

12.2

307.7

4034

6003

C07AA07

ATC

sotalol; systemic

16.3

307.7

638

423

I50.1

ICD-10 Finland

Left ventricular failure

5557.6

307.7

2458

B01AF02

ATC

apixaban; oral

14.1

307.7

1577

1359

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

6.0

307.7

973

1788

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

3903.9

307.7

383

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

307.7

429

C09AA05

ATC

ramipril; oral

6.0

307.7

4228

12316

I34.1

ICD-10 Finland

Mitral (valve) prolapse

58.9

307.7

290

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

139.9

307.7

597

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

1137.4

307.7

328

I49.5

ICD-10 Finland

Sick sinus syndrome

277.7

307.7

496

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

2123

K84

ICPC

Heart disease other

9.9

307.7

478

510

XF402

NOMESCO Finland

ECG with work load test

4.4

307.7

1324

3407

I50.0

ICD-10 Finland

Congestive heart failure

436.0

307.7

2296

Angiography of the heart and coronary arteries

5.4

307.7

941

1908

201

Kela drug reimbursment

Chronic cardiac insufficiency

162.2

307.7

3511

376

C01AA05

ATC

digoxin; systemic

57.9

307.7

1996

453

I48.2

ICD-10 Finland

Chronic atrial fibrillation

661.4

307.7

724

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

8.6

307.7

551

678

B01AA03

ATC

warfarin; systemic

17.1

307.7

3595

3570

I47.2

ICD-10 Finland

Ventricular tachycardia

906.6

307.7

961

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

14.4

307.7

404

293

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

10.8

307.7

1094

1151

1CX08, ,

NOMESCO Finland

192.5

307.7

261

I35.0

ICD-10 Finland

Aortic (valve) stenosis

29.8

307.7

481

171

I48

ICD-10 Finland

Atrial fibrillation and flutter

222.0

307.7

3754

310

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

10226.1

307.7

921

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

19.1

307.7

340

185

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

16.7

307.7

4164

4759

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

6.6

307.7

805

1324

TFP20

NOMESCO Finland

Cardiodefibrillation

328.2

307.7

1503

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

149.5

307.7

797

R06.0

ICD-10 Finland

Dyspnoea

3.7

307.7

2921

10610

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

192.4

307.7

688

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

7.9

307.7

669

917

I48.1

ICD-10 Finland

Persistent atrial fibrillation

309.5

307.7

629

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

8444.5

307.7

777

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

1127.3

307.7

428

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

118.6

307.7

635

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

4423.8

307.7

2589

WX872

NOMESCO Finland

Intensive care

5.6

307.7

676

1302

I44.1

ICD-10 Finland

Atrioventricular block, second degree

116.7

307.7

227

250, ,

Kela drug reimbursment

417.0

307.7

688

M04AA01

ATC

allopurinol; systemic

3.8

307.7

1832

5761

I47.1

ICD-10 Finland

Supraventricular tachycardia

52.1

307.7

458

XF404

NOMESCO Finland

Ambulatory ECG

22.0

307.7

1912

1119

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

56.0

307.7

646

125

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

84.9

307.7

207

Z2221

NOMESCO Finland

Medical doctor

2.7

307.7

2725

12569

C07AB07

ATC

bisoprolol; oral

12.4

307.7

6669

21111

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

3958.6

307.7

388

XFE00

NOMESCO Finland

Epicardial ultrasonography

11.7

307.7

372

331

ZXD05

NOMESCO Finland

Urgent procedure

2.6

307.7

2886

13997

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4967.6

307.7

479

ZXE00

NOMESCO Finland

One hour or less

2.4

306.9

3532

19729

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

304.0

290

C07AB02

ATC

metoprolol; systemic

2.8

300.7

1960

8369

M10.9

ICD-10 Finland

Gout, unspecified

4.0

300.1

945

2601

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

299.8

286

XF409

NOMESCO Finland

Other special ECG

58.6

287.8

161

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.5

282.6

2389

11537

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

276.0

2124

9797

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

38.5

270.4

166

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

20.8

267.9

203

100

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

261.4

1656

6918

C07AG02

ATC

carvedilol; oral

4.0

260.7

792

2118

Z3231

NOMESCO Finland

Registered nurse

2.3

258.3

2677

14064

R00.1

ICD-10 Finland

Bradycardia, unspecified

7.9

252.5

351

459

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.4

252.3

2481

12721

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

251.6

1742

7595

B01AE07

ATC

dabigatran etexilate; oral

7.7

251.1

359

485

A10BK03

ATC

empagliflozin; oral

3.2

248.9

1133

3940

R02

ICPC

Shortness of breath/dyspnoea

3.1

246.8

1215

4420

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

26.8

245.0

168

ZX120

NOMESCO Finland

Intravenous

3.2

244.6

1066

3610

TFP35

NOMESCO Finland

Electroanatomical mapping

354.7

241.7

243

I25.2

ICD-10 Finland

Old myocardial infarction

3.9

239.5

765

2116

R4110

NOMESCO Finland

Physiotherapy

2.3

238.5

2598

13856

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.2

238.1

1050

3578

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

602.8

238.1

235

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.9

235.7

541

1161

B01AF03

ATC

edoxaban; oral

19.3

231.1

181

TFJ02

NOMESCO Finland

Muscle biopsy of heart

2136.1

225.9

218

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

22.4

225.1

165

ZXD10

NOMESCO Finland

Scheduled procedure

2.1

224.1

3372

20327

I42

ICD-10 Finland

Cardiomyopathy

+∞

222.9

213

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

6.3

218.8

379

628

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.1

214.9

983

3414

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

436.9

214.6

214

K83

ICPC

Heart valve disease NOS

60.4

213.7

119

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

213.4

204

I45.9

ICD-10 Finland

Conduction disorder, unspecified

77.0

212.8

114

C01DA14

ATC

isosorbide mononitrate; oral

2.6

212.0

1474

6391

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.5

211.6

419

789

C08DA01

ATC

verapamil; systemic

6.0

210.7

380

655

127

Kela drug reimbursment

Transplant complication

8.5

208.2

271

327

FL1AC

NOMESCO Finland

Left cardioangiography

8.1

203.8

278

355

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.4

202.8

1783

8596

WX740

NOMESCO Finland

Nitrogen oxide therapy

69.7

202.3

110

4254A

ICD-9 Finland

Cardiomyopathy, Other primary cardiomyopathies

+∞

194.5

186

TK800

NOMESCO Finland

Hemodialysis

6.8

194.0

307

463

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

193.2

789

2554

Z94.1

ICD-10 Finland

Heart transplant status

225.4

192.3

198

K99

ICPC

Cardiovascular disease other

6.9

189.7

299

449

AP2

Catheterization of the right side of the heart

68.8

187.2

102

B01AF01

ATC

rivaroxaban; oral

2.8

186.0

1046

4058

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

185.1

177

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

182.1

2355

13196

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

6.3

178.6

306

501

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

+∞

176.7

169

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

176.2

1255

5469

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

175.1

3067

19097

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

174.6

167

B01AB05

ATC

enoxaparin; parenteral

2.0

173.2

2681

15982

H02AB06

ATC

prednisolone; systemic

1.9

172.8

3899

26379

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.4

172.2

664

2070

A46

ICD-10 Finland

Erysipelas

2.4

172.0

1391

6419

L04AA06

ATC

mycophenolic acid; systemic

6.8

171.1

272

412

AS4

Physiological pacemaker insertion DDD (R)

346.3

169.9

171

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.7

168.4

572

1641

AQ1

Conventional electrophysiological examination

559.3

166.7

165

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

163.0

156

Z3226

NOMESCO Finland

Physiotherapist

2.2

162.8

1636

8262

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.6

161.4

1056

4406

AA1AD

NOMESCO Finland

CT of head and brain

2.0

158.6

2343

13662

L04AD02

ATC

tacrolimus; systemic

10.0

158.4

181

184

C01BA03

ATC

disopyramide; systemic

41.8

158.0

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

33.0

157.6

101

Catheterization and pressure measurement of the right side of the heart

66.8

157.0

R55

ICD-10 Finland

Syncope and collapse

2.6

155.6

1026

4293

AP4

Myocardial biopsy

767.6

153.8

151

3A064, ,

NOMESCO Finland

61.3

153.0

K80

ICPC

Cardiac arrhythmia NOS

3.6

152.8

540

1589

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.4

152.1

580

1792

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.2

149.9

650

2172

AS7

Arrhythmia pacemaker insertion VVI (R) S

741.6

148.6

146

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

+∞

148.4

142

Electrophysiological Special Examination

1492.8

148.3

144

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.1

148.0

1717

9136

I44.0

ICD-10 Finland

Atrioventricular block, first degree

14.3

147.6

134

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

146.8

2220

12993

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

+∞

144.2

138

N19

ICD-10 Finland

Unspecified kidney failure

4.2

143.3

396

980

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

1432.0

143.1

139

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

30.3

141.5

C01BA01

ATC

quinidine; oral

39.0

138.9

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

138.9

133

E05.89

ICD-10 Finland

Other thyrotoxicosis

53.2

138.4

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

137.2

2271

13650

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.6

135.7

865

3550

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

1335.6

134.7

131

3AC01, ,

NOMESCO Finland

10.2

134.5

152

C09AA02

ATC

enalapril; systemic

2.0

133.8

1799

10059

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

44.3

133.1

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.2

132.8

561

1843

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.1

131.7

374

944

XF600

NOMESCO Finland

Bloodpressure measurement

3.1

129.8

591

2028

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

129.5

124

N18.8

ICD-10 Finland

Other chronic renal failure

4.9

129.3

293

619

ZXE20

NOMESCO Finland

More than three and less than five hours

2.2

129.3

1209

5882

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.4

128.4

258

491

I43.1*E85.9

ICD-10 Finland

Cardiac amyloidosis

+∞

127.4

122

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

+∞

127.4

122

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

+∞

127.4

122

WX722

NOMESCO Finland

PEEP

3.4

126.8

487

1508

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

6.1

125.2

221

372

TK810

NOMESCO Finland

Hemofiltration

13.0

123.8

119

M10

ICD-10 Finland

Gout

3.2

122.1

514

1683

Initial pacemaker installation

601.9

120.5

119

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.8

118.8

375

1020

M10.0

ICD-10 Finland

Idiopathic gout

3.6

117.6

403

1159

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

116.1

992

4636

Z2446

NOMESCO Finland

Social worker

2.9

115.7

584

2120

A11CC03

ATC

alfacalcidol; systemic

5.0

115.5

253

519

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.9

115.5

357

957

R04.0

ICD-10 Finland

Epistaxis

2.7

115.4

659

2553

C09AA04

ATC

perindopril; oral

3.0

114.8

554

1961

42509

ICD-8 Finland

Cardiomyopathy, Unspecified

+∞

114.8

110

E87.5

ICD-10 Finland

Hyperkalaemia

5.9

114.7

209

363

C10AA05

ATC

atorvastatin; oral

1.7

113.8

3513

25064

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

235.3

113.0

116

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

112.7

108

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.1

112.5

238

474

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

233.2

112.0

115

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

1103.4

111.8

109

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

+∞

111.7

107

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.6

111.2

683

2743

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

110.9

1406

7645

742, ,

NOMESCO Finland

52.9

110.1

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

14.5

110.0

4259X

ICD-9 Finland

Cardiomyopathy, Secondary cardiomyopathy, unspecified

+∞

109.6

105

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.6

107.8

264

594

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

106.7

1463

8165

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

106.5

102

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

20.4

106.5

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

105.7

978

4714

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

105.4

101

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.0

105.4

481

1649

I20.09

ICD-10 Finland

Unstable angina

2.9

104.7

508

1802

I51.4

ICD-10 Finland

Myocarditis, unspecified

216.8

103.8

107

Z50.0

ICD-10 Finland

Cardiac rehabilitation

7.3

103.5

153

214

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

102.8

680

2827

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

102.4

452

1520

I20.00

ICD-10 Finland

Unstable angina

3.9

101.6

302

787

ZX108

NOMESCO Finland

Inhalation

9.3

101.3

122

133

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.1

101.3

216

433

R03BB04

ATC

tiotropium bromide; inhalant

2.2

101.2

927

4446

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

100.9

918

4389

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

100.2

766

3401

C10AA01

ATC

simvastatin; oral

1.6

99.9

3610

26545

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

5.2

99.8

207

405

S97

ICPC

Chronic ulcer skin

2.8

98.6

531

1991

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

98.6

2327

15296

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

6.0

98.2

174

294

AS6

Biventricular physiological heart failure pacemaker insertion DDD (R)

+∞

98.1

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

5.3

97.8

201

390

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

+∞

97.1

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.3

96.3

384

1215

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

95.8

782

3571

R03AC02

ATC

salbutamol; inhalant

1.6

95.6

3838

28857

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

22.4

94.2

A10BH05

ATC

linagliptin; oral

2.8

92.2

488

1812

J01FF01

ATC

clindamycin; systemic

1.7

92.0

2027

13028

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

91.8

574

2320

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.7

91.2

524

2030

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

90.2

2214

14642

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

89.8

1332

7591

Catheterization and pressure measurement of the left side of the heart

5.0

89.2

192

388

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

88.7

A02BC02

ATC

pantoprazole; systemic

1.6

88.6

5127

41736

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

9.6

88.3

104

110

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.9

88.2

444

1605

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

+∞

87.6

WX882

NOMESCO Finland

High dependency care

3.7

87.0

288

808

Catheter ablation of arrhythmia

+∞

86.6

E85.9

ICD-10 Finland

Amyloidosis, unspecified

18.5

85.5

AS2

Ventricular pacemaker insertion VVI (R)

427.1

85.2

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.9

85.1

155

269

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

12.7

84.5

FM1CD

NOMESCO Finland

Very extensive CT of heart

35.6

84.3

C08DB01

ATC

diltiazem; oral

2.8

83.3

428

1564

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

416.8

83.1

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.8

82.9

428

1568

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

82.7

1994

13075

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

+∞

82.4

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

82.4

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

411.7

82.1

WX730

NOMESCO Finland

Conventional respirator

5.3

81.8

167

322

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

806.4

81.6

R53

ICD-10 Finland

Malaise and fatigue

1.8

81.3

1608

9977

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

80.3

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

+∞

80.3

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.4

80.2

296

892

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

47.3

80.1

AP3

Catheterization of the right and left side of the heart

109.9

80.0

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.7

80.0

451

1729

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

3.8

80.0

251

679

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.1

79.4

338

1111

C01BB02

ATC

mexiletine; systemic

32.1

78.8

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

9.8

78.6

I49.1

ICD-10 Finland

Atrial premature depolarization

5.3

78.6

160

308

C09AA01

ATC

captopril; oral

4.4

78.1

200

466

Q23.11

ICD-10 Finland

Bicuspid aortic valve

19.2

78.0

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.6

77.8

473

1882

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

77.7

571

2483

A10BA02

ATC

metformin; oral

1.6

77.6

2358

16356

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

765.6

77.4

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

77.2

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

3.8

77.0

240

646

I48.3

ICD-10 Finland

Typical atrial flutter

386.1

76.9

FM1DE, ,

SPAT

24.7

76.5

H03BB01

ATC

carbimazole; oral

3.3

76.2

303

956

I45.2

ICD-10 Finland

Bifascicular block

28.5

75.9

PD5BD

NOMESCO Finland

Extensive CT of aorta

4.9

75.8

168

348

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

75.4

560

2446

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.7

75.0

407

1529

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.2

74.7

307

988

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

+∞

73.0

C03AA03

ATC

hydrochlorothiazide; oral

2.1

72.6

721

3550

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.8

72.5

163

342

Initial installation of the atrial pacemaker

714.6

72.2

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.3

71.8

276

853

T92

ICPC

Gout

3.8

71.3

222

597

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

+∞

70.9

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

4.8

69.8

159

337

N17.8

ICD-10 Finland

Other acute renal failure

5.5

69.8

135

248

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.8

68.9

213

570

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

5.7

68.1

126

222

4251A

ICD-9 Finland

Cardiomyopathy, Hypertrophic obstructive cardiomyopathy

+∞

67.8

AQ2

Electrophysiological electroanatomical examination

+∞

67.8

7AX01, ,

NOMESCO Finland

663.7

67.0

R04.2

ICD-10 Finland

Haemoptysis

2.9

66.9

325

1151

I48.4

ICD-10 Finland

Atypical atrial flutter

+∞

66.7

G47.3

ICD-10 Finland

Sleep apnoea

1.6

66.7

1707

11278

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

66.6

407

1622

J01CA04

ATC

amoxicillin; systemic

1.5

66.0

5877

50822

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

65.7

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

65.6

1965

13485

XF622

NOMESCO Finland

Measurement of minute volume of heart

14.5

65.5

C09CA03

ATC

valsartan; oral

2.0

65.5

758

3944

J81

ICD-10 Finland

Pulmonary oedema

11.6

65.3

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.3

65.1

253

787

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.4

65.0

128

239

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.6

64.9

377

1466

A10AE04

ATC

insulin glargine; parenteral

2.0

64.8

764

4001

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

64.8

521

2353

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

64.7

E66.00

ICD-10 Finland

Metabolic syndrome

2.5

64.3

426

1764

K29

ICPC

Cardiovascular sympt/complt other

2.7

63.7

345

1294

T90

ICPC

Diabetes non-insulin dependent

1.6

63.7

1927

13242

I51.7

ICD-10 Finland

Cardiomegaly

319.5

63.5

A41.9

ICD-10 Finland

Sepsis, unspecified

2.9

63.4

317

1140

205

Kela drug reimbursment

Chronic hypertension

1.6

62.8

2161

15287

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.4

62.6

471

2066

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

62.6

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

+∞

62.6

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.9

62.4

306

1089

WX002

NOMESCO Finland

Sedation and analgesia

1.7

62.3

1464

9444

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.9

62.2

826

4503

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

6.1

62.2

108

179

5AB14, ,

NOMESCO Finland

20.5

61.8

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.3

61.6

485

2170

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

29.4

61.6

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

+∞

61.5

N18.0

ICD-10 Finland

End-stage renal disease

6.4

60.8

101

160

J01MA12

ATC

levofloxacin; systemic

1.7

60.6

1440

9309

K04

ICPC

Palpitations/awareness of heart

3.0

60.4

280

966

J01DB01

ATC

cefalexin; oral

1.5

59.9

6130

53910

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

59.8

1141

6948

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

59.5

2867

21734

I11

ICD-10 Finland

Hypertensive heart disease

9.9

59.5

342

Kela drug reimbursment

Dronedarone

+∞

59.4

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.9

59.2

804

4413

N02AX02

ATC

tramadol; systemic, rectal

1.5

59.0

3228

25081

L28

ICPC

Limited function/disability (L)

1.7

58.2

1290

8180

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

58.1

994

5864

WX902

NOMESCO Finland

External defibrillation of heart

92.2

57.9

H02AB07

ATC

prednisone; oral

1.8

57.6

1001

5931

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

+∞

57.3

Cardiac muscle biopsy

+∞

57.3

I43.8*M10.0

ICD-10 Finland

Gout in the heart

+∞

57.3

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.1

56.7

613

3108

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.2

56.6

150

359

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

56.5

456

2060

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.1

56.3

551

2690

Z71.8

ICD-10 Finland

Other specified counselling

1.5

56.3

1970

13933

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

194.7

56.0

R2110

NOMESCO Finland

Giving the first information

2.4

56.0

419

1832

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.3

56.0

443

1985

B01AC04

ATC

clopidogrel; oral

1.7

55.8

1286

8229

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

6.7

55.0

131

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.8

54.6

276

998

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

54.4

824

4678

R50.9

ICD-10 Finland

Fever, unspecified

1.7

54.4

1062

6497

FM1AD

NOMESCO Finland

CT of heart

22.3

54.4

E66.8

ICD-10 Finland

Other obesity

2.6

54.4

331

1316

I47.0

ICD-10 Finland

Re-entry ventricular arrhythmia

278.1

54.2

FPG42

NOMESCO Finland

Replacement of electrode(s) in transvenous cardioverter-defibrillator

+∞

54.2

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

+∞

54.2

A12AA04

ATC

calcium carbonate; oral

4.4

54.2

135

308

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

54.1

4650

39082

M01AE01

ATC

ibuprofen; systemic, rectal

0.7

54.0

5617

62552

FXG00

NOMESCO Finland

Insertion and use of IABP

16.8

53.9

I95.9

ICD-10 Finland

Hypotension, unspecified

4.2

53.8

142

339

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

53.6

3102

24236

N02BE01

ATC

paracetamol; systemic, rectal

1.6

53.5

6681

60337

A10AB05

ATC

insulin aspart; parenteral

2.1

53.4

564

2834

A10AC01

ATC

insulin (human); parenteral

2.1

53.2

545

2707

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.2

53.1

211

665

N05CF01

ATC

zopiclone; oral

1.5

52.9

2337

17317

FPJ

NOMESCO Finland

Review and replacement of pacemaker or internal defibrillator device or electrode

521.3

52.5

XFP02, ,

NOMESCO Finland

521.3

52.5

C07AB03

ATC

atenolol; systemic

2.2

52.5

440

2019

WX930

NOMESCO Finland

Thepapeutic hypothermia

+∞

52.1

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

+∞

52.1

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

51.6

1532

10414

K60

ICPC

Cardiovascular, Result test/procedure

7.1

51.5

109

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

262.3

51.1

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

51.1

42508

ICD-8 Finland

Cardiomyopathy, Alia definita

+∞

51.1

I45.3

ICD-10 Finland

Trifascicular block

73.1

51.0

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.4

50.9

187

562

J96.0

ICD-10 Finland

Acute respiratory failure

4.8

50.6

113

236

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

501.0

50.5

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

50.4

2215

16363

K79

ICPC

Paroxysmal tachycardia

12.6

50.3

E85.4

ICD-10 Finland

Organ-limited amyloidosis

19.6

50.2

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

11.1

50.1

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

50.1

2230

16513

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

50.0

L04AX01

ATC

azathioprine; systemic

2.5

50.0

314

1267

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

80.6

49.9

5CM18, ,

NOMESCO Finland

10.4

49.9

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

49.6

318

1296

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.4

49.5

123

280

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

490.9

49.4

RS221, ,

NOMESCO Finland

4.1

49.4

135

331

WW200

NOMESCO Finland

Immunization

3.0

49.3

221

748

L04AD01

ATC

ciclosporin; systemic

3.6

49.1

161

449

C01BD07

ATC

dronedarone; oral

+∞

49.0

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

12.8

48.6

J94.8

ICD-10 Finland

Other specified pleural conditions

3.8

48.2

149

399

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

48.2

1319

8781

K28

ICPC

Limited function/disability (K)

3.2

48.1

189

592

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.4

48.1

172

508

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.4

47.9

336

1428

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.6

47.8

274

1058

ZXA05

NOMESCO Finland

Left side

1.5

47.7

1816

13003

C02EA02, ,

ATC

2.3

47.7

364

1605

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

47.5

395

1806

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

18.2

47.3

PD5AD

NOMESCO Finland

CT of aorta

3.6

46.9

155

435

Z82.4

ICD-10 Finland

Family history of ischaemic heart disease and other diseases of the circulatory system

8.1

46.5

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

17.3

46.3

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

+∞

45.9

A08

ICPC

Swelling

2.3

45.6

339

1478

J01MA14

ATC

moxifloxacin; systemic

1.9

45.5

646

3586

FN1AD

NOMESCO Finland

CT of coronary arteries

4.0

45.5

131

334

TFN04, ,

NOMESCO Finland

7.7

45.4

A10BB12

ATC

glimepiride; oral

2.0

45.1

556

2947

Z82.7

ICD-10 Finland

Family history of congenital malformations, deformations and chromosomal abnormalities

13.6

45.0

A28

ICPC

Limited function/disability NOS

1.6

44.9

1237

8236

FQA00

NOMESCO Finland

Orthotopic transplantation of heart

+∞

44.8

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

+∞

44.8

UJF32

NOMESCO Finland

Coloscopy

1.5

44.6

1831

13289

AA1

Conventional CABG

3.4

44.5

161

479

SPAT1263

SPAT

Sampling

1.4

44.5

2733

21390

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.2

44.4

120

292

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.3

44.3

168

515

G04BE03

ATC

sildenafil; oral

3.1

44.2

190

628

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

44.2

279

1129

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.3

44.2

169

521

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.2

44.1

174

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

43.8

943

5901

I45.6

ICD-10 Finland

Pre-excitation syndrome

154.2

43.8

R4120

NOMESCO Finland

Occupational therapy

2.0

43.8

469

2365

FPG04

NOMESCO Finland

Insertion of internal defibrillator, atrial and chamber electrode

+∞

43.8

R18

ICD-10 Finland

Ascites

3.1

43.7

186

611

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

43.5

971

6133

212

Kela drug reimbursment

Gout

3.1

43.4

188

624

C02EA01, ,

ATC

4.1

43.2

121

302

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

430.0

43.2

SPAT1097

SPAT

Recording of ECG

1.7

43.2

962

6073

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

43.1

438

2166

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.1

43.1

118

290

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.4

42.9

296

1248

B03XA02

ATC

darbepoetin alfa; parenteral

3.2

42.7

167

522

FM1BD

NOMESCO Finland

Extensive CT of heart

13.4

42.5

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

55.9

42.4

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

42.4

1789

13038

WX213

NOMESCO Finland

Lower leg blockade

5.6

42.4

144

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

42.1

467

2385

4271A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal ventricular tachycardia

+∞

41.7

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

+∞

41.7

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

+∞

41.7

WX900

NOMESCO Finland

Resuscitation

8.6

41.7

J96.1

ICD-10 Finland

Chronic respiratory failure

3.2

41.2

163

513

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.9

41.2

127

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

8.2

41.0

R60.0

ICD-10 Finland

Localized oedema

1.7

40.7

808

4944

FPJ12

NOMESCO Finland

Revision of biventricular CRT-P (DDDR) generator

+∞

40.6

AB2

AVR bio, stent

+∞

40.6

ASA

Insertion of a biventricular pacemaker VVI (R) S

+∞

40.6

R07.3

ICD-10 Finland

Other chest pain

1.8

40.6

651

3748

B01AB04

ATC

dalteparin; parenteral

2.1

40.6

381

1827

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

7.1

40.6

R4190

NOMESCO Finland

Nutritional therapy

2.4

40.5

285

1212

NHQ40

NOMESCO Finland

Amputation of toe

3.6

40.2

134

378

Z95.9

ICD-10 Finland

Presence of cardiac and vascular implant and graft, unspecified

12.2

40.1

FXE00

NOMESCO Finland

Use of ECLA

399.5

40.1

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

399.5

40.1

SPAT1254

SPAT

Administration of medicine

1.6

40.1

969

6238

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

140.7

39.7

E66.9

ICD-10 Finland

Obesity, unspecified

2.8

39.7

207

761

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

108.1

39.7

M10.3

ICD-10 Finland

Gout due to impairment of renal function

8.1

39.6

AS5

Biventricular heart failure pacemaker insertion VVI (R)

+∞

39.6

TFP59

NOMESCO Finland

Ablation treatment of other ventricular tachycardia

+∞

39.6

4270A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal supraventricular tachycardia

+∞

39.6

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

39.6

781

4771

K05

ICPC

Irregular heartbeat other

3.2

39.5

160

511

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

39.5

620

3548

S18

ICPC

Laceration/cut

1.4

39.4

3271

26765

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

39.3

2519

19758

A10BH01

ATC

sitagliptin; oral

1.7

39.2

730

4387

XG466

NOMESCO Finland

Sleep oxymetry

2.6

39.2

230

898

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

39.1

401

1989

SPAT1255

SPAT

Intravenous administration of medicine

1.9

39.0

479

2534

XF406

NOMESCO Finland

High resolution ECG

200.9

38.8

XA800

NOMESCO Finland

Neuropsychological investigation

2.3

38.8

317

1438

I44.6

ICD-10 Finland

Other and unspecified fascicular block

105.6

38.7

I45.0

ICD-10 Finland

Right fascicular block

8.6

38.7

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

2.8

38.6

190

678

WX890

NOMESCO Finland

Intesive care monitoring

5.4

38.5

139

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

5.4

38.4

143

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

9.8

38.3

288

Kela drug reimbursment

Febuxostat

7.7

38.2

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

5.0

38.1

166

AR5

Catheter ablation of arrhythmia, target: atrial flutter

379.2

38.1

M01AH05

ATC

etoricoxib; oral

0.7

38.0

3115

37304

C09CA01

ATC

losartan; oral

1.4

37.5

1809

13478

R42

ICD-10 Finland

Dizziness and giddiness

1.5

37.3

1475

10579

M04AA03

ATC

febuxostat; oral

8.2

37.1

ZXD00

NOMESCO Finland

Emergency procedure

2.6

37.1

221

870

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

36.9

339

1612

AB1

AVR mechanical

190.8

36.8

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

130.6

36.7

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.6

36.7

217

851

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

36.6

408

2085

AC4

MVP

+∞

36.5

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.2

36.4

238

K92.1

ICD-10 Finland

Melaena

2.0

36.1

394

1999

J01DA01

ATC

[U] cefalexin

1.3

36.1

4270

36693

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

36.0

382

1919

SPAT1251

SPAT

Organisation of medication

2.5

35.9

225

907

I95.2

ICD-10 Finland

Hypotension due to drugs

5.2

35.8

141

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

6.5

35.7

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

+∞

35.4

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

+∞

35.4

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

+∞

35.4

AK1

HTX (heart transplant)

+∞

35.4

132

Kela drug reimbursment

Sarcoidosis

5.2

35.4

139

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.2

35.3

319

1508

E86

ICD-10 Finland

Volume depletion

2.7

35.2

187

695

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

4.1

35.0

232

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

34.8

304

1417

XX3BW, ,

NOMESCO Finland

123.9

34.7

SPAT1260

SPAT

Consultation of another employee

1.5

34.6

1127

7754

FM2CE, ,

NOMESCO Finland

10.0

34.5

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

34.4

211

842

XF620

NOMESCO Finland

Examination of circulation with color method

7.9

34.4

I42.3

ICD-10 Finland

Endomyocardial (eosinophilic) disease

+∞

34.4

I42.4

ICD-10 Finland

Endocardial fibroelastosis

+∞

34.4

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

+∞

34.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

34.3

691

4238

A10AE05

ATC

insulin detemir; parenteral

2.0

34.3

367

1849

R11

ICD-10 Finland

Nausea and vomiting

1.8

34.3

509

2861

XW000

NOMESCO Finland

Bone marrow biopsy

2.2

34.2

309

1461

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

34.1

201

787

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

34.1

2619

21039

I45.1

ICD-10 Finland

Other and unspecified right bundle-branch block

7.7

34.0

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

33.9

237

1005

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

33.8

294

1368

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.2

33.7

209

C02DE01, ,

ATC

5.1

33.6

138

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

+∞

33.3

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

33.3

353

1772

ZXA00

NOMESCO Finland

Right side

1.4

33.1

1854

14132

C10AX09

ATC

ezetimibe; oral

1.5

33.0

1082

7447

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

33.0

462

2548

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

33.0

383

1986

L04AA01

ATC

[U] ciclosporin

3.5

33.0

115

335

Q21.10

ICD-10 Finland

Persistent ostium secundum

9.8

32.9

FPH00

NOMESCO Finland

Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator

328.5

32.9

C01BC03

ATC

propafenone; systemic

328.5

32.9

JN4AD

NOMESCO Finland

Body CT examination

1.6

32.9

747

4724

J01FA06

ATC

roxithromycin; oral

1.4

32.7

2556

20554

I97.0

ICD-10 Finland

Postcardiotomy syndrome

11.4

32.7

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

4.3

32.6

193

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.7

32.6

103

281

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.7

32.5

101

272

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

32.5

482

2707

I51.9

ICD-10 Finland

Heart disease, unspecified

48.9

32.5

K07

ICPC

Swollen ankles/oedema

2.2

32.4

281

1306

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

32.4

780

5004

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.5

32.3

111

320

FN2EG

NOMESCO Finland

Catheter-based alcohol septal ablation

+∞

32.3

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.2

32.3

203

Q21.19

ICD-10 Finland

Atrial septal defect NOS

13.0

32.3

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

3.9

32.0

248

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

31.5

597

3599

R03BA02

ATC

budesonide; inhalant

1.5

31.5

1057

7309

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.5

31.4

106

302

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

31.4

872

5783

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.0

31.3

139

469

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

+∞

31.3

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

+∞

31.3

AT7

Replacing the pacemaker VVI (R) S

+∞

31.3

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

5.7

31.1

100

A40.8

ICD-10 Finland

Other streptococcal sepsis

5.0

30.9

133

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

30.8

476

2707

V03AE01

ATC

polystyrene sulfonate; oral

3.6

30.8

103

292

I49.2

ICD-10 Finland

Junctional premature depolarization

85.4

30.7

FM1EE, ,

SPAT

4.1

30.7

211

A04

ICPC

Weakness/tiredness general

1.6

30.6

829

5465

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

46.4

30.5

349

Kela drug reimbursment

Febuxostat

7.6

30.5

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

30.2

3352

28270

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

30.1

1908

14809

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.0

30.1

331

1684

R06

ICPC

Nose bleed/epistaxis

2.8

30.0

153

557

J01AA02

ATC

doxycycline; systemic

1.3

30.0

5571

50380

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.7

29.9

157

580

ZXE90

NOMESCO Finland

More than 22 hours

4.9

29.9

133

Z31.5

ICD-10 Finland

Genetic counselling

2.2

29.9

270

1276

TFP50

NOMESCO Finland

Ablation treatment of idiopathic right ventricle tachycardia

303.5

29.8

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

303.5

29.8

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

29.8

346

1794

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.3

29.7

110

333

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.4

29.7

211

902

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

29.6

178

705

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

29.4

1149

8185

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

5.4

29.4

109

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

29.3

850

5689

I40.0

ICD-10 Finland

Infective myocarditis

+∞

29.2

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.0

29.2

305

1524

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.5

29.1

102

298

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.9

29.1

215

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

6.0

29.0

Z94.0

ICD-10 Finland

Kidney transplant status

3.8

28.9

234

SPAT1325

SPAT

Vaccination

1.3

28.8

2290

18383

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

28.8

464

2670

FPJ02

NOMESCO Finland

Revision of ventricular pacemaker generator

293.0

28.8

SPAT1104

SPAT

Monitoring of emergency patient

1.9

28.7

403

2226

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.1

28.7

266

1271

3A149, ,

NOMESCO Finland

103.7

28.6

I45.8

ICD-10 Finland

Other specified conduction disorders

29.4

28.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

28.4

2636

21628

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

28.3

761

5004

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

5.2

28.2

113

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.8

28.2

400

2215

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

+∞

28.1

42500

ICD-8 Finland

Cardiomyopathy, Stenosis subaortae hypertrophicans

+∞

28.1

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

+∞

28.1

Coronary artery bypass surgery

2.7

28.1

151

565

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

28.0

661

4216

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

10.7

27.7

ZX197, ,

NOMESCO Finland

32.9

27.7

XF602

NOMESCO Finland

Bloodpressure monitoring

3.6

27.7

255

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

27.7

527

3179

120, ,

NOMESCO Finland

145.5

27.6

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.0

27.6

125

427

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.9

27.5

336

1772

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.9

27.5

206

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.3

27.5

213

946

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.7

27.5

145

538

3025

Kela drug reimbursment

Calcium carbonate

6.0

27.2

SPAT1081

SPAT

Cardiorespiratory global assessment

1.9

27.2

360

1950

C10AA03

ATC

pravastatin; oral

1.7

27.2

498

2973

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

5.7

27.2

RS222, ,

NOMESCO Finland

3.5

27.2

268

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

27.2

474

2792

4255A

ICD-9 Finland

Cardiomyopathy, Alcoholic cardiomyopathy

+∞

27.1

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

27.1

4797

42771

Z2445

NOMESCO Finland

Psychologist

2.2

27.0

228

1050

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.9

26.9

123

422

SPAT1252

SPAT

Overall medication plan or its review

1.8

26.9

455

2655

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

62.2

26.9

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

62.2

26.9

GEA00

NOMESCO Finland

Mediastinoscopy

6.3

26.9

A10BJ02

ATC

liraglutide; parenteral

2.4

26.9

181

756

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.6

26.9

K22

ICPC

Risk factor cardiovascular disease

1.8

26.9

384

2132

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

26.9

2161

17346

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.0

26.8

306

1577

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

26.7

305

1572

R00.2

ICD-10 Finland

Palpitations

1.9

26.6

322

1693

2BD01, ,

NOMESCO Finland

27.8

26.6

5253

FHL

Cardiac lung machine

4.6

26.5

139

C08CA02

ATC

felodipine; oral

1.6

26.5

641

4110

SPAT1285

SPAT

Provision of consultation response

1.9

26.5

343

1845

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.8

26.5

135

492

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

34.1

26.4

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.0

26.3

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

26.2

1149

8350

GD1UN

NOMESCO Finland

Lung circulation SPECT

6.1

26.2

N05BA01

ATC

diazepam; systemic, rectal

1.5

26.2

827

5632

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.7

26.1

145

552

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

26.0

TFP51

NOMESCO Finland

Ablation treatment of idiopathic left ventricle tachycardia

+∞

26.0

GD2SN

NOMESCO Finland

Lung ventilation SPECT

5.3

26.0

J20

ICD-10 Finland

Acute bronchitis

1.6

26.0

597

3781

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

25.9

311

1631

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

25.9

734

4883

R1420

NOMESCO Finland

Assessment of rehabilitation needs and/or compilation of rehabilitation plan

9.7

25.9

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

25.7

346

1884

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.9

25.7

118

406

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

25.7

465

2766

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

25.6

1190

8735

FA1AC

NOMESCO Finland

Upper cavography

93.7

25.6

K90

ICPC

Stroke/cerebrovascular accident

2.2

25.5

206

931

L17

ICPC

Foot/toe symptom/complaint

1.3

25.4

1776

13943

M10.2

ICD-10 Finland

Drug-induced gout

8.7

25.4

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

50.2

25.2

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

25.2

1667

12974

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

25.2

450

2668

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

3.3

25.1

287

H02AB04

ATC

methylprednisolone; systemic

1.5

25.1

865

5999

4029A

ICD-9 Finland

Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]

6.6

25.1

J46

ICD-10 Finland

Status asthmaticus

2.5

25.0

155

623

I51.8

ICD-10 Finland

Other ill-defined heart diseases

+∞

25.0

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

+∞

25.0

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

25.0

251

1237

SPAT1262

SPAT

Handing over of treatment supplies

1.4

24.9

1225

9079

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

24.9

494

3012

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.3

24.9

199

896

A41.8

ICD-10 Finland

Other specified sepsis

2.7

24.9

131

486

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.5

24.8

161

661

F1279, ,

NOMESCO Finland

251.0

24.7

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.3

24.7

192

855

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

7.5

24.6

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

24.5

268

1361

XF405

NOMESCO Finland

Symptom ECG

6.2

24.4

A10BJ06

ATC

semaglutide; parenteral

1.9

24.4

317

1708

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

24.3

351

1955

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

24.3

960

6837

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

24.3

393

2266

T14.5

ICD-10 Finland

Injury of blood vessel(s) of unspecified body region

5.4

24.2

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.4

24.2

259

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

24.1

398

2308

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.4

24.1

160

665

AD1

TVP

+∞

24.0

AT4

Physiological pacemaker replacement DDD (R)

+∞

24.0

WX402

NOMESCO Finland

General anaesthesia

1.4

23.9

1262

9462

SPAT1060

SPAT

Administration of oxygen

5.9

23.8

PC1BD

NOMESCO Finland

Extensive CT of thoracic aorta

6.9

23.7

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.9

23.7

108

371

AR1

Catheter ablation of arrhythmia, target: AV node reentry activation (AVNRT)

240.7

23.6

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

23.6

570

3652

H02AB09

ATC

hydrocortisone; systemic

2.4

23.6

156

647

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

23.5

859

6022

FM1CN

NOMESCO Finland

Heart perfusion isotope imaging at rest

54.2

23.0

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

3.6

22.9

210

I43.1

ICD-10 Finland

Cardiomyopathy in metabolic diseases

+∞

22.9

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

+∞

22.9

AR8

Catheter ablation of arrhythmia, target: left ventricular tachycardia

+∞

22.9

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

7.6

22.9

RS230, ,

NOMESCO Finland

5.3

22.9

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.3

22.9

167

724

A10BB01

ATC

glibenclamide; oral

1.9

22.8

279

1473

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

30.1

22.7

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

5.3

22.7

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

22.7

184

834

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

2.8

22.7

114

413

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.1

22.6

206

978

TK830

NOMESCO Finland

Ultrafiltration

230.6

22.6

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

3.5

22.6

217

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.5

22.5

139

558

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

22.5

1186

8882

A02BC01

ATC

omeprazole; systemic

1.3

22.5

1762

14032

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.0

22.4

243

1231

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

4.1

22.4

150

M79.6

ICD-10 Finland

Pain in limb

1.3

22.4

2527

21124

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.0

22.3

335

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.0

22.3

155

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

22.2

808

5659

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.9

22.2

106

374

E66.0

ICD-10 Finland

Obesity due to excess calories

3.7

22.0

188

UJF92

NOMESCO Finland

Capsular endoscopy

2.6

21.9

127

495

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

21.9

200

951

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.6

21.9

128

501

I31.1

ICD-10 Finland

Chronic constrictive pericarditis

+∞

21.9

FPH20

NOMESCO Finland

Removal of epicardial pacemaker or cardioverter-defibrillator

+∞

21.9

FPE10

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial electrode

+∞

21.9

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

+∞

21.9

E87.6

ICD-10 Finland

Hypokalaemia

2.2

21.8

194

913

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.5

21.7

134

538

WVA20

NOMESCO Finland

Medicine administration

2.3

21.7

168

747

E85.89

ICD-10 Finland

Other amyloidosis

25.1

21.7

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

115.3

21.6

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.8

21.5

177

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.8

21.5

301

1661

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.9

21.5

WW500

NOMESCO Finland

Blood transfusion

1.9

21.5

262

1383

B80

ICPC

Iron deficiency anaemia

2.6

21.4

126

495

SPAT1301

SPAT

No procedures

1.3

21.4

1983

16143

RS220, ,

NOMESCO Finland

3.0

21.3

301

NGQ20

NOMESCO Finland

Amputation of lower leg

4.9

21.3

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

21.2

1186

8962

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

4.4

21.2

118

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

3.7

21.2

179

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.3

21.1

237

V03AE02

ATC

sevelamer; oral

5.3

21.0

4278X

ICD-9 Finland

Cardiac dysrhythmias, Other specified cardiac dysrhythmias[DYSRHYTMIAE CORDIS ALIA DEFINITA]

+∞

20.8

FLE10

NOMESCO Finland

Myotomy or myectomy of left ventricle for outlet obstruction

+∞

20.8

4278A

ICD-9 Finland

Cardiac dysrhythmias, Other specified cardiac dysrhythmias[SICK SINUS-SYNDROMA]

+∞

20.8

Aortic Valve Replacement (AVR)

+∞

20.8

T82.1

ICD-10 Finland

Mechanical complication of cardiac electronic device

210.5

20.6

C01EB17

ATC

ivabradine; oral

110.3

20.6

RD210, ,

NOMESCO Finland

2.6

20.5

114

435

ZY000

NOMESCO Finland

Hospital inpatient

3.3

20.5

241

J01CF05

ATC

flucloxacillin; systemic

1.7

20.4

355

2089

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.2

20.4

177

826

137

Kela drug reimbursment

Uraemia requiring dialysis

3.7

20.1

176

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

20.1

570

3787

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

20.1

1004

7445

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

7.6

19.9

K08.3

ICD-10 Finland

Retained dental root

1.6

19.9

516

3362

ZXD35

NOMESCO Finland

Usual procedure

2.0

19.8

214

1083

FFW96

NOMESCO Finland

Other operation on atria

+∞

19.8

4260A

ICD-9 Finland

Conduction disorders, Atrioventricular block, complete

+∞

19.8

I34.02

ICD-10 Finland

Mitralysis insufficiency caused by ischemia

+∞

19.8

283

Kela drug reimbursment

Ivabradine

+∞

19.8

WX720

NOMESCO Finland

Own respiration

1.8

19.8

283

1573

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

19.8

194

949

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

19.7

239

1259

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2000

8434

2.81

316.01

4.9

1.9

31.97

29.05

54.53

1954

8211

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

937

2486

4.12

313.58

6.5

4.0

23.91

23.96

mmol/l

0.16

921

2438

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3105

13959

2.97

307.65

2.8

2.0

3.02

2.82

mg/l

3.90

2749

11610

(3012544) pH of Venous blood

1497

5242

3.27

307.65

6.1

3.5

7.38

7.39

0.34

(3022217) INR in Platelet poor plasma by Coagulation assay

5318

26661

3.82

307.65

36.2

5.8

1.57

1.10

inr

135.84

1532

7263

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

867

1353

7.04

307.65

5.7

2.5

0.36

u/ml

0.05

533

703

(3000991) Gas panel - Venous blood

1476

4542

3.74

307.65

14.3

7.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2916

10296

3.84

307.65

6.8

2.8

531.09

487.80

ng/l

0.18

2727

7952

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1434

4132

3.99

307.65

3.1

1.9

16.86

6.48

ug/l

10.76

1311

3482

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2377

3662

8.72

307.65

5.4

1.8

401.21

80.53

ng/l

99.19

2304

3209

(3022948) Iron [Moles/volume] in Serum or Plasma

3054

8189

5.34

307.65

3.4

2.2

13.31

13.69

umol/l

1.71

2919

7540

(3023368) Bacteria identified in Blood by Culture

3174

16486

2.51

307.65

5.8

3.9

—

(3016502) Oxygen saturation in Arterial blood

1557

5540

3.23

307.65

12.8

6.7

94.90

95.98

6.67

1512

5329

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2498

8873

3.61

307.65

6.5

3.4

0.82

0.81

mmol/l

0.43

2372

8260

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4245

22190

2.89

307.65

3.9

2.5

173.60

163.01

ug/l

0.78

4023

20186

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

783

1279

6.66

307.65

2.5

1.7

11.08

10.93

mg/l

0.18

726

1191

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

933

2183

4.69

307.65

2.4

1.7

33.39

39.25

u/l

10.29

681

1965

(3002032) Base excess in Venous blood by calculation

1465

5071

3.30

307.65

6.0

3.5

1.75

1.70

mmol/l

0.20

1257

4218

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2892

6979

5.85

307.65

3.4

2.2

22.64

24.35

7.71

2600

5858

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2939

7489

5.55

307.65

3.4

2.1

2.32

2.28

g/l

2.74

2794

6841

(3027456) Digoxin [Moles/volume] in Serum or Plasma

716

104.47

307.65

3.0

1.5

0.80

0.93

nmol/l

0.44

551

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1955

7382

3.16

307.65

8.6

5.2

1.10

1.01

mmol/l

34.76

1841

6860

(3014111) Lactate [Moles/volume] in Serum or Plasma

1429

4751

3.43

307.65

12.6

6.0

1.47

1.36

mmol/l

2.63

1381

4616

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1462

5082

3.28

307.65

6.0

3.5

5.88

5.77

kpa

3.96

1420

4951

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5722

13273

11.89

307.65

7.4

1.8

2534.49

568.80

ng/l

121.37

5432

10658

(3003396) Base excess in Arterial blood by calculation

1712

6225

3.21

307.65

12.0

6.3

0.69

0.92

mmol/l

1.21

1387

4878

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1723

6244

3.23

307.65

12.0

6.3

5.00

5.09

kpa

2.71

1637

5953

(3020779) Urea [Moles/volume] in Serum or Plasma

1757

4768

4.41

307.65

14.6

6.0

12.15

9.20

mmol/l

39.28

1681

4523

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4129

21517

2.85

307.65

6.2

2.7

87.15

75.84

ng/l

0.13

3382

15142

(3027801) Oxygen [Partial pressure] in Arterial blood

1720

6242

3.22

307.65

12.0

6.3

11.25

12.79

kpa

33.21

1632

5946

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2024

8971

2.67

286.82

2.1

1.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4407

27691

2.27

282.70

10.9

5.2

1.19

1.21

mmol/l

64.60

4169

24916

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1400

5142

3.08

282.00

13.8

7.0

123.51

123.44

g/l

0.04

1382

4987

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1544

6072

2.90

274.50

2.0

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4809

31630

2.25

271.75

8.9

6.4

14.37

11.78

umol/l

27.36

4630

29968

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4703

30669

2.25

271.23

11.5

5.8

1.20

1.22

mmol/l

73.26

4066

25876

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

893

2531

3.84

271.04

3.9

3.2

4.19

4.52

pmol/l

14.08

828

2229

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1525

6046

2.87

266.44

2.0

1.6

—

(3018418) pH of Serum or Plasma

3171

17752

2.28

264.40

5.7

3.7

7.40

0.41

607

3243

(3013826) Glucose [Moles/volume] in Serum or Plasma

5250

36137

2.25

260.35

9.0

4.0

6.95

6.80

mmol/l

4.60

5050

33737

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

952

2896

3.59

259.77

15.7

8.0

24.10

24.23

mmol/l

0.54

910

2819

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1606

6632

2.77

259.06

7.2

4.4

261.02

243.60

u/l

3.27

1526

6235

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2301

11626

2.36

240.16

4.4

1.6

1.49

1.38

mg/l

0.68

1819

9048

(3001604) Monocytes [#/volume] in Blood

4484

29672

2.12

236.37

7.9

5.6

0.64

0.61

e9/l

12.66

3905

25254

(3006315) Basophils [#/volume] in Blood

4485

29760

2.12

233.72

8.0

5.7

0.04

e9/l

0.35

3905

25339

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

992

3317

3.26

231.89

14.5

6.2

24.51

24.71

mmol/l

0.80

984

3287

(3013115) Eosinophils [#/volume] in Blood

4586

30765

2.11

231.12

8.4

5.9

0.19

0.20

e9/l

4.52

4026

26534

(3019198) Lymphocytes [#/volume] in Blood

4542

30578

2.08

224.01

8.0

5.7

1.76

1.97

e9/l

8.14

4011

26638

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

791

2363

3.60

220.62

1.8

1.6

1.54

1.58

g/l

0.57

683

2003

(3033658) Prothrombin time (PT) actual/Normal

2784

15716

2.17

218.23

6.3

3.6

73.07

92.59

204.89

2722

15372

(3020630) Protein [Mass/volume] in Serum or Plasma

1238

4914

2.79

212.34

2.7

2.5

64.54

66.97

g/l

21.57

1151

4422

(3024354) Oxygen [Partial pressure] in Venous blood

1112

4171

2.93

212.01

5.3

3.0

4.55

kpa

0.00

1070

4040

(3022096) Basophils/100 leukocytes in Blood

4124

27200

2.04

210.39

8.3

5.9

0.63

0.67

5.65

3948

25103

(3006504) Eosinophils/100 leukocytes in Blood

4205

28075

2.02

205.63

8.3

5.9

2.70

2.96

11.80

4030

25953

(3019069) Monocytes/100 leukocytes in Blood

4218

28262

2.01

203.41

8.5

6.2

9.02

8.78

5.61

4043

26163

(3044889) 12 lead EKG panel

5854

44135

2.13

202.83

7.1

3.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1471

6522

2.53

201.06

2.6

2.4

1.86

1.69

7.95

1321

5676

(40760892) CBC W Ordered Manual Differential panel - Blood

4154

27822

2.00

199.02

8.6

6.2

—

(3021589) Normoblasts [#/volume] in Blood

4060

27003

1.99

198.18

13.6

8.8

0.00

e9/l

0.16

3331

21982

(3024561) Albumin [Mass/volume] in Serum or Plasma

4034

26833

1.99

196.17

6.2

4.7

34.11

35.49

g/l

40.56

3791

24773

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

659

1883

3.72

195.82

4.1

2.1

702.51

659.03

ug/l

0.06

636

1767

(3002030) Lymphocytes/100 leukocytes in Blood

4271

29030

1.98

194.48

8.4

6.0

24.32

27.76

75.45

4100

26960

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

552

1407

4.13

192.69

5.1

2.5

3.59

3.60

g/l

0.05

526

1349

(3003434) Protein [Mass/volume] in Pleural fluid

341

583

6.06

190.56

1.6

1.3

26.87

38.19

g/l

37.51

283

544

(3018010) Neutrophils/100 leukocytes in Blood

4198

28566

1.96

188.32

8.2

5.7

60.21

57.04

54.08

4021

26524

(40758558) Short blood count panel - Blood

2621

15142

2.07

187.67

8.9

7.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4858

34814

1.97

186.10

10.8

9.2

4.48

4.13

e9/l

18.82

4258

30116

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2993

18282

2.00

182.40

2.9

2.0

301.25

230.25

u/l

0.73

2847

17070

(3042936) Bacteria identified in Isolate by Culture

1674

8236

2.30

179.24

2.7

1.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

531

1391

4.01

178.32

5.1

2.4

210.89

190.11

5.86

514

1323

(3023199) Leukocytes [#/volume] in Pleural fluid

318

545

6.03

177.18

1.6

1.3

4174.95

3144.04

e6/l

0.13

217

402

(3026493) Urate [Moles/volume] in Serum or Plasma

2725

16366

1.99

172.11

3.7

2.5

2460.40

5459.86

umol/l

5.08

2395

14215

(3028308) Erythrocytes [#/volume] in Pleural fluid

299

502

6.14

170.08

1.5

1.3

28007.75

61823.03

e6/l

2.03

179

314

(3024928) Oxygen saturation in Venous blood

413

929

4.63

169.23

5.2

3.0

—

(3036489) Thrombin time

630

1924

3.46

168.63

4.7

1.9

22.55

21.06

3.69

586

1684

(3012441) Differential panel - Pleural fluid

286

465

6.34

167.99

1.5

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

555

1570

3.72

166.82

6.2

2.1

87.97

91.20

2.69

545

1500

(3045788) Cell count panel - Pleural fluid

268

411

6.71

166.61

1.6

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

841

3083

2.92

165.32

18.0

8.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

188

199

9.64

159.71

38.0

32.0

7.79

7.51

ug/l

0.53

175

177

(3019060) Gas panel - Arterial blood

897

3485

2.77

157.86

6.2

4.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3014

19188

1.90

156.79

3.5

3.3

44.58

35.07

u/l

1.98

2846

18085

(3042733) HLA Ab [Presence] in Serum

158

142

11.32

150.53

4.5

4.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

578

1798

3.38

149.90

4.0

3.1

51.63

77.09

mg/l

0.39

480

1490

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

577

1794

3.38

149.76

4.0

3.1

46.25

43.31

mg/l

0.20

478

1486

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

559

1746

3.36

143.92

4.0

3.1

1.98

3.01

ratio

0.56

138

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6051

48760

1.91

140.10

10.9

7.3

82.31

79.61

u/l

3.41

5818

45626

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1355

6733

2.21

138.26

3.0

2.8

9.59

10.04

umol/l

0.33

1208

5921

(3030467) Casts [#/volume] in Urine by Automated count

2784

17835

1.85

137.84

3.8

3.1

0.81

0.41

e6/l

4.11

2196

13471

(3004119) Hemoglobin [Mass/volume] in Venous blood

818

3249

2.69

137.10

5.2

2.9

128.77

130.49

g/l

1.13

792

3176

(36304419) Bacteria [Presence] in Urine

2693

17108

1.85

136.74

3.7

3.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

427

1178

3.77

132.68

2.4

2.7

32.65

36.16

umol/l

1.74

385

1065

(3023520) Reticulocytes [#/volume] in Blood

1068

4880

2.37

132.66

2.7

2.5

74.17

66.68

e9/l

6.54

773

3713

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

817

3314

2.63

131.05

1.8

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

915

3929

2.49

130.29

1.7

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

2951

19514

1.80

129.79

3.8

3.2

82.23

90.02

e6/l

0.16

2339

14894

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

403

1114

3.75

124.78

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

403

1114

3.75

124.78

1.4

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

1298

6597

2.15

124.01

2.3

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1168

5702

2.22

123.46

2.2

2.3

0.20

0.22

g/l

10.41

1076

5336

(40760888) Immunoglobulin light chains.free panel - Serum

436

1315

3.44

118.28

3.9

3.2

—

(40768806) Pleura Pathology biopsy report

252

506

5.11

117.99

1.6

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

224

405

5.66

117.81

1.3

6.72

5.47

mmol/l

5.54

211

365

(3022493) Free Hemoglobin [Mass/volume] in Plasma

154

187

8.37

117.51

29.8

1.2

73.62

1473.54

mg/l

0.52

137

124

(3018095) Leukocytes [#/volume] in Urine

3208

22208

1.73

117.08

4.4

3.6

79.58

92.81

e6/l

0.51

2431

15868

(3008152) Bicarbonate [Moles/volume] in Arterial blood

793

3368

2.50

115.00

9.7

6.1

24.26

24.52

mmol/l

0.98

762

3183

(3052851) Hemolysis interference index of Serum or Plasma

508

1718

3.09

114.11

4.8

3.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

912

4147

2.35

113.62

2.7

2.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

292

685

4.38

113.12

8.7

5.8

11.08

11.43

mg/l

0.58

265

629

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

898

4090

2.34

111.35

5.3

3.6

125.34

82.63

ng/l

20.86

814

3501

(3009445) Proteinase 3 Ab [Units/volume] in Serum

625

2410

2.72

110.28

1.3

1.6

10.22

18.01

u/ml

—

(3010375) cycloSPORINE [Mass/volume] in Blood

162

226

7.29

109.80

24.3

26.6

117.61

117.83

ug/l

0.01

109

198

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

216

408

5.41

108.31

1.4

1.2

407.03

745.05

u/l

0.76

203

387

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

588

2217

2.78

108.30

2.5

2.2

10.00

10.22

g/l

0.59

536

1930

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

504

1759

2.99

107.01

2.6

2.2

0.01

0.04

g/l

1.65

460

1606

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

612

2377

2.70

106.37

2.6

2.2

3.58

3.74

g/l

2.25

562

2108

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

612

2383

2.69

105.83

2.6

2.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

736

3136

2.48

105.68

1.5

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

612

2385

2.69

105.65

2.6

2.2

7.30

7.41

g/l

0.70

562

2112

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

588

2247

2.74

105.47

2.6

2.2

3.08

2.88

g/l

4.56

539

1975

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

474

1611

3.06

105.43

2.6

2.2

0.00

g/l

-0.00

434

1485

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

478

1637

3.04

104.91

2.6

2.2

0.00

g/l

0.17

434

1490

(3000850) Epithelial cells [#/volume] in Urine

2104

13245

1.79

104.78

2.9

2.5

4.83

4.34

e6/l

1.22

1924

11779

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

296

746

4.08

104.25

1.5

1.2

3.26

3.62

u/ml

0.31

149

315

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

368

1105

3.44

100.35

9.6

5.0

904.20

2098.17

iu/ml

0.39

162

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

337

956

3.63

100.24

1.7

1.4

115.12

107.29

u/ml

1.01

191

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

294

767

3.94

98.70

1.5

1.2

2.63

4.52

u/ml

0.89

110

245

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

536

2034

2.75

97.29

2.7

2.3

0.59

1.05

g/l

2.69

469

1725

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

357

1074

3.43

97.04

1.7

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1083

5608

2.07

96.76

2.6

2.5

57.37

63.57

u/l

0.10

931

4867

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

461

1625

2.95

95.99

1.9

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

505

1871

2.81

95.92

2.6

2.1

36.14

38.27

g/l

10.29

452

1591

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5347

43602

1.65

95.39

4.5

3.5

15.31

14.79

pmol/l

35.38

4955

38765

(3037522) Nuclear Ab [Titer] in Serum

1258

6933

1.96

94.16

1.3

459.66

502.14

titre

0.32

232

1380

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

332

972

3.52

94.11

1.5

1.3

285.46

266.79

u/ml

0.56

248

606

(3017143) Hepatitis C virus Ab [Presence] in Serum

1051

5445

2.07

93.58

1.8

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

386

1265

3.15

91.22

5.2

3.0

8.15

8.33

kpa

1.16

379

1240

(1616796) Gas panel - Central venous blood

362

1148

3.25

90.36

5.0

2.9

—

(3044640) Blood type and Crossmatch panel - Blood

2768

19400

1.64

90.20

3.2

2.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1775

11047

1.77

89.88

3.2

2.8

1.19

1.05

e6/l

0.65

985

6322

(3018405) Lactate [Moles/volume] in Arterial blood

486

1826

2.77

89.79

5.6

3.7

1.41

1.38

mmol/l

0.23

477

1799

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

341

1047

3.35

89.69

1.5

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

366

1174

3.22

89.65

5.6

3.3

8.20

8.73

kpa

5.83

359

1145

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

551

2211

2.60

89.35

2.2

1.8

4.49

2.25

ug/l

0.42

498

1959

(3024932) HLA-DR beta [Type]

125

168

7.54

87.55

1.0

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1274

7214

1.91

87.41

1.9

1.6

—

(3024471) HLA-A [Type]

125

172

7.36

85.76

1.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1682

10456

1.76

84.90

3.3

3.0

2.43

1.81

e6/l

1.72

895

5760

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1101

6001

1.96

84.43

1.8

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2201

14769

1.67

83.81

3.1

2.3

—

(3020891) Body temperature

519

2090

2.58

83.44

6.7

4.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

779

3757

2.19

83.12

5.3

3.2

5.11

5.10

kpa

0.12

742

3538

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

750

3568

2.21

82.78

5.2

3.2

1.96

1.46

mmol/l

2.51

541

2621

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

358

1188

3.10

82.76

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

336

1077

3.21

82.35

3.2

2.2

16.25

16.78

1.21

183

570

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

376

1288

3.01

82.25

1.5

1.4

—

(3026782) Osmolality of Urine

1971

12919

1.69

81.73

3.2

2.8

524.17

572.38

mosm/kgh2o

22.75

1728

11021

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

363

1226

3.05

81.39

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

618

2730

2.37

81.27

4.6

2.9

24.98

25.06

mmol/l

0.22

596

2656

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

422

1554

2.81

80.89

1.5

1.4

11.49

14.74

iu/ml

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

477

1873

2.64

80.68

1.5

1.6

142.50

275.92

titre

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

172

347

5.04

80.06

1.3

1.2

10.63

16.35

u/l

1.35

153

333

(3009343) pH of Capillary blood

764

3714

2.17

79.77

5.3

3.2

7.41

7.42

1.98

139

389

(3013290) Carbon dioxide [Partial pressure] in Blood

350

1172

3.07

79.64

5.7

3.3

4.87

4.97

kpa

1.47

343

1144

(3012501) Base excess in Blood by calculation

350

1172

3.07

79.64

5.7

3.3

2.64

2.39

mmol/l

0.76

230

765

(3010421) pH of Blood

383

1352

2.92

79.37

5.6

3.2

7.42

0.06

346

1235

(3035880) pH of Pleural fluid

139

233

6.05

79.08

1.3

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

13.63

78.34

1.4

1.2

4.16

542867.41

nmol/l

0.71

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

266

760

3.58

78.19

1.4

1.1

96.17

119.41

17.27

261

679

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

127

201

6.40

76.51

6.1

1.4

21.34

776.32

ug/l

1.30

121

182

(3021879) Hepatitis B virus core Ab [Presence] in Serum

737

3597

2.15

76.04

1.5

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

269

790

3.49

75.82

1.3

1.1

—

(3021901) Oxygen saturation in Capillary blood

301

952

3.24

75.39

3.6

2.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

202

489

4.21

75.05

2.5

2.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4905

40303

1.54

74.68

5.0

4.1

1395.51

1436.26

e6/l

0.02

600

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1081

6098

1.89

74.12

4.4

3.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

119

184

6.55

73.33

2.4

1.8

189.46

143.09

6.23

113

172

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

201

497

4.12

72.59

2.9

2.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

196

478

4.18

72.11

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2637

19035

1.57

72.11

3.0

2.5

60.92

66.02

u/l

0.61

2471

17483

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

307

1011

3.12

71.84

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

408

1570

2.68

71.74

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

350

1245

2.89

71.47

2.6

1.9

130.82

131.24

g/l

0.09

239

873

(3022806) Fractional oxyhemoglobin in Capillary blood

225

613

3.75

70.96

2.0

1.7

89.66

89.72

0.05

220

605

(3048929) Epstein Barr virus Ab [Presence] in Serum

385

1449

2.74

70.69

1.5

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

143

275

5.27

70.30

1.2

—

(3026008) Bacteria identified in Urine by Culture

2433

17326

1.57

70.19

3.2

3.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

476

1995

2.47

70.13

2.4

2.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2092

14401

1.61

69.63

1.7

1.5

19.07

20.24

nmol/l

3.25

1875

12138

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3666

28682

1.50

67.72

3.2

2.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

257

788

3.33

67.68

2.2

1.7

1.71

1.74

mmol/l

0.18

252

772

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

378

1458

2.67

66.10

1.4

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

647

3167

2.13

65.95

2.0

1.9

1.30

1.40

g/l

0.39

602

2858

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

273

896

3.12

64.24

1.5

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

390

1561

2.57

63.25

5.6

3.8

1.86

1.40

mg/l

19.70

362

1420

(3014148) Varicella zoster virus Ab [Titer] in Serum

196

539

3.70

60.99

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

354

1376

2.64

60.93

1.5

1.4

0.23

0.24

g/l

0.81

331

1290

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

363

1431

2.61

60.72

1.5

1.4

1.17

1.20

g/l

0.95

343

1344

(3037756) Immunofixation for Serum or Plasma

323

1201

2.76

60.65

1.7

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

259

853

3.10

60.58

4.5

2.9

3719.58

10251.12

u/ml

0.35

(3005719) IgG [Mass/volume] in Serum or Plasma

772

4157

1.95

60.27

2.7

2.6

10.23

10.61

g/l

1.54

722

3772

(21494890) Protein electrophoresis panel - 24 hour Urine

201

568

3.60

60.07

2.4

2.1

—

(3034426) Prothrombin time (PT)

102

167

6.17

59.46

1.4

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

226

697

3.31

58.96

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6264

55419

1.55

58.87

5.4

4.2

2.11

2.23

mu/l

0.62

5846

49508

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

252

835

3.08

58.33

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

252

835

3.08

58.33

1.6

—

(3051651) Icteric interference index of Serum or Plasma

147

342

4.36

57.55

6.8

3.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

332

1286

2.65

57.52

1.2

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

5312

45558

1.47

56.95

5.1

3.8

15.13

11.86

mm/h

35.09

4985

41659

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6900

62618

1.63

56.10

28.0

12.4

25.45

26.68

mg/l

2.51

6105

48724

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

524

2515

2.16

55.97

5.2

3.3

45.95

47.47

0.71

517

2482

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

166

436

3.86

55.20

1.1

1.2

101.82

174.59

titre

1.20

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

8.80

55.17

1.6

1.2

83.30

84.63

0.08

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

257

890

2.95

55.05

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

190

556

3.47

53.87

1.6

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

190

556

3.47

53.87

1.6

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

193

572

3.43

53.65

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

199

605

3.35

53.14

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

8.75

52.54

1.5

1.2

80.76

64.33

1.99

(3051611) Lipemic interference index of Serum or Plasma

201

624

3.28

51.90

5.9

2.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

838

4850

1.81

51.87

2.4

381.29

372.58

nmol/l

0.54

795

4468

(3012516) Albumin [Mass/volume] in Urine

2631

20031

1.46

51.57

3.5

3.2

401.91

364.31

mg/l

0.18

1911

12865

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3314

26379

1.43

50.93

2.2

1.9

91.43

94.34

pmol/l

2.97

1823

13922

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

170

5.58

49.48

2.8

1.8

12509.46

2285.73

e6/l

0.88

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

817

4757

1.80

49.46

3.4

2.5

52.86

67.86

ml/min/173m2

24.79

371

1760

(3009508) Creatinine [Moles/volume] in Urine

2707

20852

1.44

49.34

3.4

3.2

7.21

8.06

mmol/l

22.03

2304

17434

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

141

358

3.99

49.19

1.7

1.3

13.37

11.67

u/l

2.30

136

347

(3002385) Erythrocyte distribution width [Ratio]

6040

53706

1.47

49.11

33.5

15.1

15.14

15.12

0.09

5958

52600

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

8.18

49.06

6.1

6.7

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

12.37

48.65

4.3

4.0

70.63

58.50

0.98

(3009871) Measles virus Ab [Titer] in Serum

159

5.71

48.57

1.2

1.8

—

(3013512) EKG study

2393

18143

1.45

46.96

6.5

3.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2710

21158

1.42

44.78

4.0

3.8

15.17

6.26

mg/mmol

12.25

1901

13522

(3015377) Calcium [Moles/volume] in Serum or Plasma

2684

20952

1.42

44.25

3.7

3.5

2.34

2.35

mmol/l

6.89

2335

18228

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

206

713

2.94

44.20

1.3

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

200

682

2.98

44.07

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

8.22

43.98

5.9

7.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

217

776

2.84

43.87

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1437

9979

1.53

43.09

1.6

1.4

2.61

2.55

g/l

0.48

913

5798

(3047189) Immunofixation for 24 hour Urine

110

258

4.31

42.69

1.9

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

204

4.75

42.14

3.0

1.9

604.57

3516.56

e6/l

0.64

144

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

145

5.56

42.05

1.4

1.3

62.28

57.09

0.50

128

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

239

923

2.64

41.66

1.2

1.4

30.87

33.58

u/l

0.14

219

780

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

298

1286

2.37

41.00

1.4

1.5

—

(3000492) Spirometry study

879

5565

1.65

38.81

1.6

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

7127

66426

1.55

38.14

37.8

14.0

139.33

139.70

mmol/l

26.93

7028

64466

(3033799) Differential panel - Peritoneal fluid

179

4.79

37.74

2.5

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

138

5.40

37.74

1.6

1.4

18.13

10.26

g/l

10.07

(3002331) Protein [Mass/volume] in Peritoneal fluid

121

5.74

37.57

1.7

1.3

31.72

34.00

g/l

0.07

(3022313) Gas panel - Capillary blood

510

2789

1.88

37.51

5.8

3.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4888

42830

1.35

36.35

4.9

4.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1630

12000

1.45

35.78

1.8

1.7

1228.21

1110.39

nmol/l

5.16

1293

8814

(3023103) Potassium [Moles/volume] in Serum or Plasma

7131

66655

1.53

35.66

38.2

14.1

4.06

3.99

mmol/l

95.02

7025

64579

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

35.43

2.2

0.0

—

(3006576) Bicarbonate [Moles/volume] in Blood

134

5.26

34.71

6.0

5.1

25.50

24.81

mmol/l

0.72

126

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

119

345

3.48

34.34

1.4

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

6.62

33.93

1.3

52.32

220.55

ng/l

1.10

(3001893) Eosinophils/100 leukocytes in Pleural fluid

130

5.27

33.77

1.3

2.92

3.03

0.03

117

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

443

2401

1.89

33.45

7.0

4.5

1.69

1.62

0.84

417

2247

(3011397) Hemoglobin [Presence] in Urine by Test strip

1831

13932

1.40

33.06

3.8

3.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

169

621

2.76

32.54

2.9

2.4

1.62

1.19

g/24h

0.78

273

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

326

1612

2.06

32.06

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

210

870

2.45

31.68

1.2

1.4

—

(3044007) Cell count panel - Peritoneal fluid

161

4.63

31.64

3.4

1.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

431

2364

1.87

31.35

7.2

4.5

0.86

0.90

1.45

406

2212

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

103

289

3.60

31.26

1.2

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

103

289

3.60

31.26

1.2

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

315

1558

2.06

30.96

1.3

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

173

4.42

30.73

1.2

1.1

—

(3004451) EKG impression Narrative

194

4.21

30.68

1.1

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2889

23828

1.33

30.63

2.6

2.1

75.44

77.97

nmol/l

4.68

2620

21000

(42529406) Shigella sp [Presence] in Stool by Culture

315

1565

2.05

30.59

1.3

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

102

5.62

30.43

1.5

1.3

24.33

23.33

0.08

(3035947) Staphylolysin Ab [Units/volume] in Serum

226

3.92

30.35

1.2

1.1

3.29

2.50

iu/ml

—

(3007566) Smooth muscle Ab [Titer] in Serum

296

1443

2.09

30.24

1.2

126.33

105.79

titre

0.16

114

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

310

1546

2.04

29.80

1.3

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

8.84

29.77

1.2

56.78

790.92

u/l

0.65

(3014891) Appearance of Pleural fluid

9.03

29.44

1.6

1.3

—

(3047181) Lactate [Moles/volume] in Blood

343

1787

1.96

29.14

8.1

5.3

1.48

1.28

mmol/l

2.09

312

1562

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

8.29

29.07

1.3

1.4

14.81

13.57

0.06

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

771

5065

1.58

28.85

5.2

3.4

1.21

1.23

mmol/l

11.27

714

4342

(3025941) Bacteria identified in Stool by Culture

496

2913

1.75

28.73

1.4

1.2

—

(3021788) Differential panel - Synovial fluid

237

1085

2.22

28.43

1.5

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1522

11516

1.39

27.75

3.0

3.3

2.46

2.45

mmol/l

1.93

1303

10086

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

155

592

2.65

27.73

3.5

3.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

126

434

2.93

27.41

1.4

1.1

—

u/ml

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

7.12

26.24

1.3

1.1

1.17

2.30

mmol/l

0.42

(3003181) Sodium [Moles/volume] in Urine

218

998

2.22

26.18

1.6

1.3

60.91

65.41

mmol/l

0.80

169

798

(3000919) Neutrophils/100 leukocytes in Pleural fluid

125

4.75

26.10

1.4

1.2

23.49

23.27

0.02

117

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

151

589

2.59

25.92

1.6

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

233

1100

2.15

25.91

1.5

1.7

50.66

4.15

iu/l

0.48

357

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

167

4.16

25.83

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

117

403

2.93

25.48

1.4

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

143

548

2.64

25.45

1.6

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

424

2466

1.76

25.39

6.3

3.4

24.65

24.71

mmol/l

0.18

402

2259

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6358

59095

1.33

25.16

6.9

5.8

42.05

40.05

mmol/mol

37.47

5987

53972

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6457

60154

1.34

25.13

27.8

11.9

72.05

79.64

ml/min/173m2

117.91

5793

49000

(21494755) Public health laboratory ask at order entry panel

263

4917

0.52

24.27

1.3

1.4

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

7.58

24.17

1.4

1.2

65.81

71.25

0.31

(3041918) Cholesterol [Moles/volume] in Pleural fluid

5.58

23.91

1.3

1.1

1.38

2.12

mmol/l

3.11

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

211

990

2.16

23.87

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

200

920

2.20

23.77

4.7

2.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

210

3.64

23.69

1.9

2.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

289

3.21

23.50

1.2

1.3

33.48

22.78

u/l

1.46

241

(3023419) Bacteria identified in Sputum by Culture

186

838

2.25

23.26

2.0

2.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4446

39693

1.26

22.85

3.8

3.0

73.15

52.08

u/l

24.92

4148

36498

(3023420) DNA double strand Ab [Units/volume] in Serum

128

500

2.58

21.98

1.5

1.3

54.63

26.16

iu/ml

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

122

466

2.64

21.91

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

122

466

2.64

21.91

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

122

466

2.64

21.91

1.6

1.7

—

(3044941) Cell count panel - Synovial fluid

192

901

2.16

21.74

1.4

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

298

3.08

21.71

1.2

1.3

114.04

89.19

u/l

1.23

254

(3042631) Mycobacterium sp identified in Specimen

180

825

2.21

21.62

2.2

2.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

269

1435

1.90

21.36

1.7

1.6

16038.48

12925.10

e6/l

0.43

182

1040

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

277

4888

0.55

20.99

1.6

1.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

124

4.30

20.80

1.1

1.2

64.77

87.47

3.49

(3010838) Calcium [Moles/time] in 24 hour Urine

190

914

2.10

20.21

2.0

1.9

4.78

5.17

mmol/24h

0.93

169

785

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

123

4.25

20.13

1.1

1.2

58.13

89.15

4.29

(3017569) Oxygen content in Arterial blood

240

3.23

19.98

2.6

2.1

—

(40761511) CBC panel - Blood by Automated count

6898

65437

1.34

19.77

25.1

11.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

400

2455

1.66

19.68

2.1

1.8

—

(1761868) Lipid panel - Serum or Plasma

1759

21435

0.77

19.65

3.2

2.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

5.85

19.59

7.2

6.9

—

(3035350) Ketones [Presence] in Urine by Test strip

3394

29706

1.24

19.54

4.1

3.4

0.00

estimate

3.18

743

5745

(3017181) Myelocytes/100 leukocytes in Blood

739

5211

1.46

19.51

4.6

4.0

0.77

0.99

2.69

316

1803

(3021601) Nitrite [Presence] in Urine by Test strip

3392

29705

1.24

19.38

5.3

4.6

0.00

estimate

0.80

715

5355

(3051593) INR in Capillary blood by Coagulation assay

206

3.37

19.20

12.7

2.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

197

983

2.03

19.02

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

205

1039

2.00

18.95

1.6

—

(40768797) Stomach Pathology biopsy report

1082

8195

1.37

18.95

1.2

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

129

544

2.39

18.88

1.2

75.23

68.49

u/l

0.12

117

480

(3000494) Fungus identified in Specimen by Culture

962

7160

1.39

18.74

1.6

1.4

—

(3000012) Reticulocyte production index

171

815

2.12

18.67

2.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

20.83

18.57

1.3

1.1

128.53

164.33

ug/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

241

3.13

18.53

2.3

1.9

—

(3018572) Chloride [Moles/volume] in Blood

237

1273

1.89

18.47

10.0

6.2

104.39

105.20

mmol/l

1.45

218

1138

(3039000) Anion gap in Blood

237

1273

1.89

18.47

9.9

6.2

11.95

11.25

mmol/l

2.18

218

1138

(3040151) Glucose [Moles/volume] in Capillary blood

143

637

2.27

18.47

9.6

6.2

7.08

7.58

mmol/l

1.25

122

533

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

293

2.89

18.01

1.3

1.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

6.27

17.98

1.1

1.0

15.97

25.90

u/l

1.25

(3009261) Glucose [Presence] in Urine by Test strip

3413

30074

1.23

17.92

4.1

3.5

0.00

estimate

0.14

663

5155

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

344

2.72

17.87

1.3

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

366

2252

1.65

17.84

1.9

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

180

892

2.04

17.74

1.5

1.6

0.75

0.90

g/l

0.81

134

676

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

936

6996

1.38

17.73

1.8

1.64

1.52

3.29

787

6107

(3004716) Salmonella sp identified in Stool by Organism specific culture

376

2340

1.64

17.53

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

294

2.84

17.32

1.3

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

315

1880

1.70

17.25

1.2

0.33

1.00

u/ml

1.63

181

(40757494) Bilirubin.total [Moles/volume] in Blood

236

3.07

17.23

1.9

2.1

22.24

43.65

umol/l

—

(3002179) Metamyelocytes/100 leukocytes in Blood

667

4723

1.45

17.18

4.5

3.8

0.56

0.72

0.95

267

1546

(3021440) Promyelocytes/100 leukocytes in Blood

694

4952

1.44

17.15

4.6

4.0

0.07

0.12

1.34

270

1555

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

165

803

2.08

17.09

1.2

1.3

—

(3017704) Immunofixation for Urine

313

2.77

17.06

1.7

1.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

156

744

2.12

17.04

1.3

0.74

2.39

nmol/l

0.55

150

719

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

156

745

2.11

16.98

1.3

0.24

0.39

nmol/l

0.55

(3037121) Protein [Mass/volume] in Urine

342

2100

1.66

16.82

2.7

3.4

0.36

0.29

g/l

0.82

178

976

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

310

1856

1.70

16.78

5.3

1.4

6.48

4.09

mg/l

2.16

282

1334

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1164

9070

1.33

16.76

1.3

1.2

41.57

37.38

iu/ml

0.34

345

2827

(3019977) pH of Arterial blood

279

2.85

16.59

2.4

2.2

7.42

7.41

0.50

100

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

101

413

2.46

15.88

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

144

685

2.12

15.87

1.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

26.30

15.56

3.1

9.6

—

(3025159) Blasts/100 leukocytes in Blood

651

4674

1.43

15.53

4.7

3.9

0.34

0.44

0.13

225

1282

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

139

658

2.13

15.52

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

190

1011

1.90

15.31

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

103

433

2.40

15.27

1.1

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

120

540

2.24

15.21

3.1

2.7

—

(4200892) Spirometry reversibility

609

4338

1.44

15.17

1.5

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

376

2.49

15.01

1.9

2.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.46

14.91

3.7

5.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

122

561

2.19

14.68

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6327

59919

1.24

14.67

4.7

3.9

1.42

1.32

mmol/l

13.80

5905

53862

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

170

3108

0.54

14.53

1.4

1.5

—

(40761535) Cells panel - Urine sediment

695

5106

1.39

14.51

3.9

3.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

169

881

1.94

14.51

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.97

14.30

1.3

1.1

—

(3015736) pH of Urine

2714

23754

1.21

14.23

3.8

3.2

5.74

5.80

0.29

104

1551

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3713

33512

1.20

13.91

2.7

2.5

—

(4035726) Immunohistochemistry procedure

775

5842

1.36

13.80

2.0

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

345

2.48

13.64

1.3

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

170

913

1.88

13.37

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

116

544

2.15

13.33

1.4

1.3

7.57

6.83

g/l

0.92

379

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

248

1496

1.68

13.13

1.5

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

300

2.55

12.95

2.0

1.7

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

115

544

2.13

12.94

1.4

1.3

2.89

3.03

g/l

0.35

382

(3024139) IgG subclass 3 [Mass/volume] in Serum

115

544

2.13

12.94

1.4

1.3

0.47

0.41

g/l

0.80

376

(3020564) Creatinine [Moles/volume] in Serum or Plasma

7063

67984

1.28

12.77

35.4

14.7

95.70

79.58

umol/l

131.25

7056

67952

(3044927) Protein electrophoresis panel - Urine

125

614

2.05

12.75

1.3

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

285

2.58

12.73

1.1

1.08

1.06

ratio

0.31

101

(4062490) Immunoglobulin typing, IgG

114

543

2.11

12.62

1.4

1.3

—

(40761536) Microorganisms panel - Urine sediment

657

4904

1.37

12.43

4.4

3.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

182

2.98

12.43

1.1

0.21

0.91

g/l

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

130

655

2.00

12.37

1.3

—

nmol/l

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

4.01

12.34

2.3

2.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1372

11330

1.25

12.26

1.2

1.3

1.83

2.04

u/ml

0.18

337

2848

(3029937) Albumin [Presence] in Urine by Test strip

1868

15971

1.22

12.03

4.6

3.8

0.00

estimate

0.14

653

5091

(44786800) Granulocytes/100 leukocytes in Body fluid

5.01

11.92

1.1

1.3

23.35

30.92

0.37

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

116

3.46

11.77

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

350

2.33

11.40

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

350

2.33

11.40

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

114

3.43

11.35

1.2

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

351

2.32

11.33

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

377

2.27

11.27

1.3

1.2

36.15

36.04

mmol/l

0.01

314

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.54

11.15

1.0

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

200

2.76

11.07

1.6

1.8

730.80

50888.68

u/ml

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

355

2.29

11.05

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

355

2.29

11.05

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

355

2.29

11.05

1.2

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

230

2.62

10.92

1.4

2.2

69.85

138.88

umol/l

2.19

121

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

125

653

1.93

10.78

1.1

—

(3011412) CD3 cells [#/volume] in Blood

105

517

2.04

10.71

2.2

2.6

1.04

1.13

e9/l

0.47

463

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

174

1013

1.73

10.58

1.2

1.3

214.29

205.23

miu/ml

0.10

412

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

5.01

10.50

2.7

1.9

74.21

54.28

1.47

(3001964) Herpes simplex virus Ag [Presence] in Specimen

157

2.94

10.41

1.2

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.69

10.38

1.3

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

278

2.42

10.36

3.4

4.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

202

2.68

10.33

4.0

1.8

—

(21494434) Karyotype in Bone marrow

108

546

1.99

10.26

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2357

26445

0.85

10.04

3.8

4.4

22.78

21.90

1.81

1058

13509

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.48

9.86

1.1

1.2

0.87

0.66

umol/24h

0.80

(3008536) Aspergillus sp Ab [Presence] in Serum

115

3.23

9.82

1.5

2.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

147

835

1.77

9.77

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.01

9.55

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

428

3111

1.40

9.55

1.4

1.3

228.58

295.86

u/ml

0.95

407

2866

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

137

769

1.79

9.49

1.1

1.68

1.50

g/l

5.76

130

689

(3039443) Prostate specific Ag panel - Serum or Plasma

1735

0.51

9.47

1.7

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1030

8485

1.24

9.24

1.2

12.83

14.56

u/ml

0.32

370

3131

(3003338) MCHC [Mass/volume]

5566

52835

1.17

9.21

38.2

16.3

330.25

333.42

g/l

115.38

5506

52393

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

136

775

1.77

8.98

1.4

1.5

67.10

56.67

2.31

479

(40768446) Kidney Pathology biopsy report

213

2.50

8.83

1.8

1.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.79

8.81

3.2

3.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

383

2771

1.40

8.80

1.4

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

134

2.92

8.78

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.01

8.77

1.2

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

212

1366

1.57

8.73

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

251

1681

1.51

8.67

2.1

2.2

119.23

96.60

ug/min

0.47

137

1023

(3000060) B lymphocytes [#/volume] in Blood

147

2.80

8.56

2.0

2.4

236.67

287.40

e6/l

0.13

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

147

2.80

8.56

1.3

1.2

16.02

531.29

ug/l

1.69

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

248

1662

1.51

8.55

1.4

1.5

1.58

2.54

iu/ml

0.19

363

(3029075) Extractable nuclear Ab panel - Serum

131

2.91

8.51

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

285

2.26

8.51

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

286

2.25

8.44

1.7

1.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

195

2.52

8.36

1.1

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.08

8.24

1.3

—

(3024263) Appearance of Synovial fluid

315

2.17

8.23

1.3

1.4

—

(3011985) Renin [Units/volume] in Plasma

129

744

1.75

8.21

1.3

1.5

66.06

55.28

mu/l

0.27

117

669

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

409

2.01

8.18

1.0

1.1

304.03

280.11

mg/l

1.94

371

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

152

918

1.67

8.18

1.2

48.86

37.17

u/ml

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3024

32940

0.87

8.17

4.2

5.2

2.64

3.60

ug/l

3.04

2653

29594

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

118

2.97

8.17

1.2

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

130

755

1.73

8.08

1.5

—

(3045142) Bone marrow Pathology biopsy report

128

741

1.74

8.05

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

170

2.60

7.98

1.7

1.6

9.27

9.37

ug/l

0.04

170

(3001686) Cold agglutinin [Titer] in Serum or Plasma

3.14

7.93

1.2

1.3

64.40

278.17

titre

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

123

708

1.75

7.90

1.2

1.4

317.47

464.68

pmol/l

0.48

103

600

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

4.43

7.88

5.3

2.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

104

570

1.83

7.87

1.3

1.74

1.37

nmol/l

2.32

517

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

4.62

7.86

2.9

1.8

5.50

24.11

2.09

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6996

67922

1.20

7.80

15.7

9.8

28.83

27.08

u/l

4.84

6801

65013

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

121

702

1.73

7.58

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

200

1318

1.53

7.51

1.2

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

109

2.94

7.36

1.3

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

680

8364

0.80

7.34

4.9

4.6

32.13

32.04

0.07

540

5399

(3036525) Urea [Moles/time] in 24 hour Urine

8.35

7.30

2.5

3.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6440

62173

1.16

7.28

5.1

4.4

1.29

1.43

mmol/l

144.32

6042

56391

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

110

2.92

7.25

1.0

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

199

1324

1.52

7.17

1.2

28.42

36.83

u/ml

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6491

62737

1.16

7.09

5.2

4.4

4.21

4.63

mmol/l

192.86

6123

57293

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

349

2.01

7.05

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

218

2.30

7.05

1.2

1.1

8.40

5.53

u/ml

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

350

2.01

7.00

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

242

1688

1.45

6.90

1.5

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

409

1.92

6.82

1.8

1.6

—

(3028433) Virus identified in Specimen by Culture

197

2.34

6.77

1.2

1.1

—

(3049717) Cytology report of Urine Cyto stain

386

2924

1.34

6.72

2.6

2.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

161

1040

1.56

6.66

1.2

1.24

4.05

u/ml

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

378

1.94

6.63

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

169

2.43

6.57

1.8

1.9

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.10

6.57

1.3

1.1

96.42

99.51

0.16

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

312

2.03

6.50

2.4

2.2

73.21

159.49

ug/min

0.58

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

474

1.82

6.47

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

375

1.93

6.45

2.2

2.7

475.72

532.02

e6/l

0.29

311

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

183

2.36

6.44

1.4

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

113

676

1.68

6.40

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1858

16631

1.15

6.38

1.4

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

342

1.97

6.36

1.7

1.6

5.50

6.91

u/l

0.36

280

(3008037) Lactate [Moles/volume] in Venous blood

204

1406

1.46

6.23

4.5

2.6

1.60

1.61

mmol/l

0.07

195

1375

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

469

1.80

6.08

1.4

1.6

31.64

24.93

u/ml

0.30

114

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6616

64218

1.15

6.08

5.7

4.9

2.45

2.75

mmol/l

136.12

6223

58360

(40768800) Prostate Pathology biopsy report

156

2329

0.66

6.05

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

246

1775

1.40

5.87

1.3

1.4

280.64

263.34

ug/g

0.28

164

1081

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

386

1.85

5.63

1.3

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

145

958

1.52

5.50

1.8

1.9

20.07

25.48

ug/l

1.10

140

941

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

105

2.67

5.48

1.8

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

361

1.86

5.48

2.3

2.8

0.19

0.25

e9/l

1.17

310

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6396

62054

1.14

5.47

5.2

4.6

6.29

6.02

mmol/l

38.34

5884

55862

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

181

1253

1.45

5.46

1.2

5.51

6.52

u/ml

0.23

197

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

166

2.29

5.42

1.2

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

231

2.08

5.41

1.2

154.84

179.23

mmol/24h

1.24

231

(3035320) C reactive protein [Mass/volume] in Body fluid

392

1.82

5.38

2.7

2.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

438

1.76

5.29

2.1

2.6

641.03

620.12

e6/l

0.10

425

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

260

1928

1.36

5.29

1.7

1.6

—

(3049233) Organic acids panel - Urine

11.26

5.28

1.1

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.67

5.24

1.1

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

234

2.06

5.24

1.7

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

234

2.06

5.24

1.7

2.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

155

1050

1.49

5.24

3.2

3.5

1.51

1.65

0.19

142

909

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.64

5.19

1.0

1.3

2.08

1.68

umol/24h

0.54

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.19

5.07

1.6

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

364

1.82

5.05

2.0

2.8

42.24

36.08

1.48

182

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

272

1.95

5.04

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

557

6711

0.82

4.95

2.4

2.1

12.37

12.81

nmol/l

0.61

493

5988

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

176

1238

1.43

4.92

1.2

5.56

3.17

u/ml

0.45

120

(3001019) Free T4 and TSH panel - Serum or Plasma

153

2192

0.69

4.86

1.6

—

(3038515) Glucose [Moles/volume] in Venous blood

189

1351

1.41

4.84

4.8

2.6

7.39

7.69

mmol/l

1.04

181

1326

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

235

2.01

4.82

1.7

2.1

—

(3002619) Bacteria identified in Specimen by Culture

119

2.44

4.78

2.0

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

567

1.63

4.76

1.3

1.5

22.36

31.31

1.94

338

(3008295) Osmolality of Serum or Plasma

598

1.61

4.76

1.5

1.4

274.82

282.14

mosm/kgh2o

1.97

464

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

3.16

4.75

4.2

2.5

1.34

1.40

mg/l

0.03

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.67

1.1

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

111

721

1.55

4.62

3.6

3.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

360

0.28

4.56

1.0

—

(4281824) Cell count and differential, peritoneal fluid

535

1.63

4.56

1.5

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.86

4.48

1.3

1.2

—

mmol/l

—

(3045414) Leukocytes [Presence] in Urine

336

2651

1.28

4.45

2.0

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1759

19253

0.89

4.44

2.7

3.1

0.79

ug/l

0.01

1251

13112

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.79

4.43

1.0

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

202

2.03

4.41

1.3

—

(3048879) Bone marrow aspiration report

182

2.09

4.40

1.7

1.8

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

344

1.78

4.39

1.8

1.5

9.40

5.95

u/l

0.53

286

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

353

1.76

4.32

1.3

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.34

4.31

1.1

—

(3022145) Colonoscopy Study observation

815

7055

1.17

4.31

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

399

1.71

4.27

1.3

622.22

596.25

titre

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

576

1.59

4.27

1.6

1.3

161006.52

92779.26

e6/l

0.34

381

(21494814) CD8 cells/100 lymphocytes in Specimen

212

1.99

4.24

1.6

1.8

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.84

4.21

1.9

0.92

1.59

mmol/l

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

364

1.74

4.19

1.3

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

153

2.16

4.16

2.7

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

153

2.16

4.16

2.7

2.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

510

1.61

4.14

1.4

1.3

1.19

1.37

promille

0.56

406

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.24

4.13

1.3

1.7

1.23

0.84

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.24

4.13

1.3

1.7

1.38

3.24

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.24

4.13

1.3

1.7

0.28

2.22

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.24

4.13

1.3

1.7

0.73

2.10

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.24

4.13

1.3

1.7

0.11

1.29

mg/l

—

(3014051) Protein [Presence] in Urine by Test strip

205

1537

1.34

3.98

2.3

2.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

290

1.80

3.92

3.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

243

1.86

3.77

1.4

1.7

3.31

17.01

nmol/l

0.77

202

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

8.76

3.77

11.7

5.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.59

3.74

1.5

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

923

8158

1.15

3.72

14.9

5.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

323

3989

0.80

3.70

1.4

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

274

1.79

3.68

1.0

1.1

—

(4034850) Laboratory test

250

1952

1.29

3.67

17.7

8.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

672

0.53

3.59

1.3

191.41

180.19

pmol/l

0.19

672

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.65

3.55

1.3

1.8

—

(3046861) Legionella sp Ag [Presence] in Urine

4.77

3.55

1.1

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

112

780

1.44

3.43

3.6

1.9

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

254

1.78

3.31

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

254

1.78

3.31

1.3

1.5

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

3.93

3.28

1.1

—

(36660697) Celiac disease serology panel - Serum

492

4184

1.19

3.28

1.1

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

123

2.12

3.19

2.0

2.4

8.34

8.10

mmol/l

0.09

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

586

1.49

3.18

1.3

1.2

—

36.40

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

309

2525

1.23

3.13

2.7

3.7

2219.01

1765.84

u/ml

0.11

256

2221

(3019174) dRVVT (LA screen)

3.25

3.13

1.3

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

320

1.66

3.10

1.9

1.75

2.86

u/field

0.80

222

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

162

1226

1.33

3.05

1.3

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

365

3044

1.21

3.04

1.2

135.46

132.85

iu/ml

0.04

110

1080

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.29

2.99

2.9

4.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.29

2.99

3.0

4.5

—

(3016135) IgD [Mass/volume] in Serum

5.39

2.86

4.4

1.2

35.01

77.60

mg/l

—

(40768443) Skin Pathology biopsy report

337

2809

1.21

2.84

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.29

2.83

1.3

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

172

1331

1.30

2.79

2.2

1.8

1.16

0.76

nmol/l

4.92

147

1117

(3020393) Adenovirus Ag [Presence] in Stool

2.22

2.79

1.6

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

555

0.56

2.77

1.0

297.00

329.73

ng/l

0.24

373

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.92

2.77

3.7

2.1

—

(3018291) Platelet Ab [Presence] in Serum

8.34

2.75

1.2

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

145

1.93

2.74

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.24

2.72

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

6.00

2.69

1.3

1.1

1826.67

2016.66

umol/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

445

1.51

2.68

1.5

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

100

718

1.40

2.67

1.8

2.3

845.47

2745.99

u/l

1.48

250

(3009542) Hematocrit [Volume Fraction] of Blood

7158

70563

1.11

2.62

42.1

18.6

40.14

40.69

3.92

6750

65351

(3048689) Calprotectin [Mass/mass] in Stool

711

6332

1.13

2.61

1.9

2.3

136.51

150.24

ug/g

0.50

562

5004

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

557

0.57

2.61

1.0

34.57

41.76

ng/l

0.63

368

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

391

3333

1.18

2.60

2.5

2.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

554

0.58

2.56

1.0

716.76

735.40

ng/l

0.09

360

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.06

2.56

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

253

1.66

2.54

1.0

—

(3007461) Platelets [#/volume] in Blood

7159

70599

1.11

2.52

40.6

18.6

230.66

245.41

e9/l

64.44

7011

68217

(3017354) Segmented neutrophils/100 leukocytes in Blood

676

1.39

2.51

3.0

3.6

63.47

56.10

2.98

549

(3008116) Ketones [Moles/volume] in Urine by Test strip

122

1.97

2.49

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

255

1.65

2.47

1.2

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.38

2.47

1.3

2.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

277

2301

1.21

2.47

1.1

57.22

222.11

titre

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.24

2.43

1.5

1.7

—

(3035941) MCH [Entitic mass]

7160

70638

1.10

2.40

40.4

18.5

30.49

30.46

0.84

7064

69321

(3052592) Norovirus Ag [Presence] in Stool

117

1.97

2.39

1.6

1.3

—

(3024731) MCV [Entitic volume]

7160

70643

1.10

2.38

40.4

18.5

92.20

91.20

57.21

7066

69322

(3026361) Erythrocytes [#/volume] in Blood

7160

70648

1.10

2.36

40.6

18.6

4.42

4.54

e12/l

55.56

6997

67984

(3050794) Legionella sp Ab [Presence] in Serum

2.61

2.35

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

7161

70664

1.10

2.34

40.9

18.6

133.61

137.37

g/l

68.71

7067

69330

(3010813) Leukocytes [#/volume] in Blood

7160

70656

1.10

2.33

40.6

18.6

7.16

6.74

e9/l

25.80

6995

68002

(3044009) aPTT.lupus sensitive (LA screen)

2.75

2.27

1.5

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

581

0.62

2.23

2.8

13.24

13.16

0.17

573

(40757373) Influenza virus identified in Isolate

107

1.96

2.19

1.2

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

458

1.44

2.19

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

369

3185

1.17

2.16

1.7

1.8

—

(3022621) pH of Urine by Test strip

460

4038

1.15

2.15

2.8

—

(3036180) Methadone [Presence] in Urine

204

1.67

2.13

1.9

2.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

358

0.53

2.10

1.4

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.20

2.09

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

331

0.51

2.08

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

331

0.51

2.08

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

331

0.51

2.08

1.2

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

284

1.55

2.07

1.2

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

330

0.51

2.07

1.2

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.70

2.06

6.5

5.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

278

1.55

2.02

1.1

86.82

85.21

u/l

0.07

250

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

279

1.54

1.99

1.1

23.03

25.98

u/l

0.23

247

(3014271) Vancomycin [Susceptibility]

331

1.48

1.90

3.4

2.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

541

1.37

1.88

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

300

1.50

1.86

1.2

1.5

3.18

3.61

0.11

(3047352) Trisomy 18 risk [Likelihood] in Fetus

278

0.50

1.85

1.1

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

301

1.50

1.84

1.6

2.4

5.21

12.70

umol/l

1.60

213

(3005033) Fetal Nuchal fold Thickness US

277

0.50

1.84

1.1

1.4

—

(3002256) Pathology report gross observation

919

8476

1.09

1.83

1.3

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.17

1.82

7.8

6.6

550.60

454.08

umol/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

108

841

1.29

1.80

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

284

0.53

1.73

1.3

1.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.85

1.71

4.8

7.2

—

(3007463) Buprenorphine [Presence] in Urine

3.85

1.71

1.4

6.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

133

1.73

1.69

1.4

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

111

1.80

1.68

1.2

1.3

1.76

75.27

mg/l

0.78

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1447

13647

1.07

1.67

1.7

27356574.08

29553224.46

pmol/l

0.05

1199

11136

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.16

1.66

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

157

1896

0.82

1.63

5.1

3.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

408

3630

1.13

1.62

1.2

1.3

61.09

62.03

au/ml

0.02

220

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

782

7204

1.09

1.62

3.2

4.5

9.66

27.36

ug/l

5.08

647

6030

(40765096) Chromosome analysis panel by Banding

205

1.56

1.61

1.1

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2391

22941

1.06

1.61

4.5

3.6

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.57

1.61

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

395

3514

1.13

1.58

1.8

1.9

—

(4212803) Bone marrow aspirate examination

2.11

1.54

1.2

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

322

1.43

1.54

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

161

1.62

1.52

1.1

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

138

1.67

1.51

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

138

1.67

1.51

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

138

1.67

1.51

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

138

1.67

1.51

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

170

1.59

1.48

1.1

—

(40768795) Lymph node Pathology biopsy report

609

1.30

1.47

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

715

1.28

1.47

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

715

1.28

1.47

1.3

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.92

1.43

1.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

718

1.27

1.43

1.3

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

156

1.60

1.43

1.7

—

(3004775) Volume in Urine collected for unspecified duration

577

1.30

1.43

2.1

2.2

661.02

662.73

0.01

389

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

739

1.26

1.39

1.3

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

554

1.30

1.38

1.1

1.2

—

(3016750) Collection duration of Urine

398

1.36

1.38

2.0

2.1

507.06

498.89

min

0.24

302

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

127

1.66

1.36

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.94

1.36

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.94

1.36

1.0

1.2

—

mmol/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

173

1470

1.18

1.34

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

199

1.51

1.34

3.1

3.2

59.18

54.38

0.61

190

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.84

1.29

1.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

720

1.25

1.29

1.3

1.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.78

1.28

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.78

1.28

5.4

5.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.89

1.28

3.3

5.8

69.85

45.84

ug/min

0.60

(3019150) Specific gravity of Urine by Refractometry

1366

12994

1.06

1.24

4.8

3.9

1.02

kg/l

2.89

184

2054

(40768804) Tissue Pathology biopsy report

2608

25240

1.05

1.24

2.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.86

1.23

1.0

1.1

—

(3019225) pH of Specimen

698

6488

1.08

1.23

6.0

3.8

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.63

1.21

1.0

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

164

1.53

1.19

1.2

1.3

37.06

37.96

0.04

111

(3040893) Potassium [Moles/volume] in Capillary blood

2.31

1.18

5.2

2.0

4.35

4.33

mmol/l

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

332

1.36

1.18

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

121

1011

1.20

1.17

1.1

114.67

1007.16

iu/ml

0.77

210

(3005011) Chlamydia sp Ab [Titer] in Serum

1.77

1.16

1.4

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.00

1.16

1.6

1.7

52.10

45.64

umol/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

128

0.47

1.16

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.73

1.14

1.3

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

502

1.28

1.11

1.9

2.0

1.27

1.82

u/field

0.47

190

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

438

4011

1.10

1.11

2.3

2.4

14.28

23.20

au/ml

1.78

272

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.26

1.10

1.3

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

201

1.44

1.09

1.1

1.2

38.07

38.66

g/l

0.07

102

(3017509) Phencyclidine [Presence] in Urine

1.95

1.08

1.5

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.73

1.08

1.5

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.73

1.08

1.5

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.73

1.08

1.5

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

268

0.63

1.08

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

268

0.63

1.08

1.2

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

720

1.22

1.07

1.3

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

267

0.64

1.07

1.0

1.1

669.67

359.08

ng/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

150

1738

0.86

1.06

2.3

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

633

1.23

1.04

3.1

3.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.27

1.03

1.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

392

3587

1.10

1.03

3.1

2.7

0.46

0.29

e6/l

1.19

386

3519

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.06

1.02

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

179

1.45

1.02

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

300

1.33

0.98

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

969

0.82

0.97

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

132

1.52

0.96

1.4

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.80

0.96

1.6

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

124

1.53

0.96

1.9

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

137

1182

1.16

0.96

1.6

2.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

279

2525

1.11

0.94

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

125

1.52

0.93

1.4

1.3

—

(3051339) Copper [Moles/volume] in Blood

2.22

0.93

1.0

1.2

19.01

16.10

umol/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

172

0.58

0.93

1.0

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.72

0.92

1.3

6.73

6.01

mmol/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

295

1.32

0.92

1.2

1.1

7.95

11.27

iu/ml

0.62

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

322

1.31

0.90

1.0

1.1

—

(40768441) Liver Pathology biopsy report

464

1.25

0.90

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

719

0.81

0.89

1.1

1.2

8.08

7.58

mmol/l

0.58

606

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

792

1.19

0.89

3.2

3.4

8.46

13.25

nmol/l

0.29

777

(3026389) Candida sp identified in Specimen by Organism specific culture

737

1.20

0.89

1.4

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.91

0.88

1.3

1.4

50.63

21.67

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.91

0.88

1.0

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.91

0.88

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

368

1.28

0.87

1.3

2.21

2.06

u/ml

0.04

208

(3012494) Peanut IgE Ab [Units/volume] in Serum

119

1.51

0.87

1.0

1.1

1.02

37.98

u/ml

—

(40768793) Breast Pathology biopsy report

979

0.84

0.87

1.2

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

497

5316

0.93

0.84

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1740

16832

1.04

0.84

1.6

1.51

1.37

mmol/l

4.45

1473

14060

(3029396) Erythrocyte agglutination [Presence] in Blood

1.78

0.84

1.6

2.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

196

1.38

0.83

1.6

2.23

5.14

ug/l

1.18

149

(3009214) Lutropin [Units/volume] in Serum or Plasma

168

1490

1.13

0.83

1.5

1.4

10.19

8.45

u/l

0.91

134

1201

(3020491) Glucose [Moles/volume] in Blood

452

1.24

0.83

2.0

1.8

8.37

6.80

mmol/l

1.54

303

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

178

0.62

0.82

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.69

0.82

1.0

1.2

0.70

1.51

u/ml

0.42

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

165

0.61

0.81

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.64

0.81

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.70

0.80

1.1

1.0

6.50

12.62

u/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1119

0.86

0.79

1.4

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

600

1.20

0.79

1.3

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

349

0.74

0.77

7.3

6.4

51.00

9051.59

u/ml

—

(3023410) Appearance of Cerebral spinal fluid

621

1.19

0.76

1.5

1.7

—

(3042517) Benzodiazepines panel - Urine

1.77

0.76

2.2

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.77

0.76

1.0

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.08

0.74

1.2

1.5

37.60

12.12

nmol/l

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.08

0.74

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

141

1.42

0.74

1.2

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

141

1.42

0.74

1.3

1.2

1101.54

252.68

pmol/l

0.45

105

(3050129) First trimester maternal screen panel - Serum or Plasma

403

0.77

0.74

1.7

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

278

0.72

0.74

1.1

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

108

1.48

0.73

2.3

1.5

192.44

130.11

ng/l

0.48

108

(3016031) Almond IgE Ab [Units/volume] in Serum

2.00

0.72

1.0

1.1

0.56

1.86

u/ml

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.80

0.72

1.9

2.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.75

0.71

2.4

3.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

168

1.37

0.71

1.4

1.2

0.30

g/l

0.02

133

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

224

2042

1.10

0.71

2.8

4.0

80.75

67.88

u/ml

0.36

216

1972

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

109

1.47

0.70

2.6

2.7

100.87

133.90

ng/l

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

207

2274

0.91

0.70

1.6

1.7

39.67

41.79

nmol/l

0.74

202

2192

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.71

0.70

6.3

6.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

169

0.65

0.68

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.85

0.68

1.0

1.1

282.40

277.64

nmol/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.85

0.68

1.0

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.67

0.68

1.7

2.7

25.36

19.46

mg/l

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

227

0.70

0.67

2.1

2.9

27.70

29.00

umol/l

—

173

(3015183) Erythrocyte sedimentation rate

250

0.72

0.67

1.4

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

284

1.27

0.67

2.1

2.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

164

1477

1.11

0.67

1.7

2.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.63

0.66

13.3

7.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

267

1.27

0.66

1.5

1.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

111

1.44

0.65

1.1

1.6

2.27

2.37

ug/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

155

0.64

0.65

1.4

1.2

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.72

0.64

1.0

1.1

283.20

729.83

u/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

323

1.24

0.63

1.3

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

148

1333

1.11

0.62

2.0

1.7

335.21

297.98

mu/l

0.60

139

1239

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

324

1.24

0.62

1.3

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

217

1.29

0.61

1.0

1.1

1388.57

1560.63

miu/ml

0.34

217

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

164

0.67

0.61

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

113

1.42

0.61

1.3

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

271

1.26

0.60

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.48

0.60

1.1

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

722

1.15

0.60

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

723

1.15

0.59

1.2

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

0.20

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

582

6107

0.95

0.59

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

677

1.15

0.58

1.3

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

649

0.85

0.58

1.0

1.1

—

17.64

—

(3000330) Specific gravity of Urine by Test strip

353

3317

1.07

0.57

3.9

3.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

355

1.21

0.57

1.3

1.54

1.18

nmol/l

0.89

269

(3032773) Endomysium IgG Ab [Titer] in Serum

463

0.82

0.57

1.1

—

(3025577) Chromium [Mass/volume] in Blood

484

0.83

0.56

2.1

1.9

1.77

2.11

ug/l

0.49

399

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

150

1.33

0.55

2.0

2.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

180

1650

1.09

0.55

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.58

0.54

1.2

1.4

28.83

9.20

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.48

0.53

2.0

2.6

0.11

0.30

u/field

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.54

0.53

1.3

1.0

—

(4146454) Self-monitoring of blood glucose

790

0.87

0.52

2.7

2.8

—

(3025130) Human papilloma virus identified in Specimen

415

1.18

0.51

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.50

0.51

1.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.50

0.51

1.3

1.4

308.33

332.85

umol/24h

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

816

7873

1.04

0.50

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

122

1106

1.10

0.49

2.5

2.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

363

1.19

0.48

1.2

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

153

1405

1.09

0.48

1.4

28.67

28.70

iu/l

0.00

119

1177

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

177

0.73

0.47

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.47

0.47

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.41

0.46

1.2

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

299

0.80

0.46

9.6

12.0

0.51

0.64

mmol/l

2.08

272

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

122

1338

0.91

0.46

1.2

1.1

9.58

7.59

u/ml

0.20

155

(3004616) Nuclear Ab [Presence] in Serum

664

1.13

0.46

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

120

1.33

0.46

1.0

1.1

—

(1002224) Polysomnography panel

217

2320

0.93

0.45

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

152

1646

0.92

0.44

1.7

1.9

210.34

203.36

pmol/l

0.36

143

1545

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

104

1.35

0.43

1.0

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

218

0.78

0.42

2.1

2.4

138.06

145.45

nmol/l

0.12

189

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.56

0.42

1.4

1.7

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

1.56

0.42

1.2

1.3

1.00

0.86

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.43

0.41

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

594

0.87

0.41

1.5

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

2.2

—

3.19

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

418

1.15

0.39

1.1

1.2

4.33

2.72

u/ml

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

171

0.76

0.39

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.43

0.39

1.8

1.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.43

0.39

4.0

4.6

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.43

0.39

1.0

1.1

—

4.64

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

105

0.67

0.39

1.0

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

105

0.67

0.39

6.0

5.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.39

0.0

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1623

15913

1.02

0.39

3.9

3.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

106

0.66

0.39

3.0

2.9

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

115

1.30

0.38

1.0

—

(3016879) Cocaine [Presence] in Urine

144

1336

1.08

0.38

2.6

2.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

548

0.88

0.38

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

307

1.17

0.38

1.1

1.01

1.08

u/l

0.52

161

(3023511) Choriogonadotropin [Units/volume] in Urine

307

1.17

0.38

1.4

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

270

1.19

0.38

2.6

2.2

63.24

52.14

umol/l

0.77

224

(3020650) Glucose [Presence] in Urine

158

0.76

0.37

1.1

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.39

0.36

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

157

0.76

0.35

2.5

2.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.66

0.35

1.0

1.1

—

(44813793) Dust mix specific IgE antibody measurement

348

1.15

0.34

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

255

1.18

0.34

2.0

1.8

26.80

29.51

umol/l

1.19

246

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

172

1.22

0.34

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

358

1.15

0.34

1.0

1.1

1.95

11.04

nmol/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

254

0.83

0.34

1.1

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

476

0.88

0.32

1.4

1.3

22.64

27.08

u/l

0.48

383

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.73

0.30

1.0

1.2

—

(3017732) Neutrophils [#/volume] in Blood

435

4202

1.04

0.30

2.9

6.29

4.97

e9/l

0.60

337

3267

(3008898) HLA-B27 [Presence]

147

1561

0.94

0.29

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

141

0.78

0.29

7.8

6.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

439

1.12

0.29

1.1

1.2

2.20

49.24

u/ml

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

919

1.08

0.29

1.7

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.29

0.28

1.9

1.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

224

1.16

0.27

1.0

1.1

7.46

6.77

u/ml

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.69

0.26

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

386

3738

1.03

0.25

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.20

0.25

1.0

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.25

0.24

2.1

2.7

89.01

60.56

pmol/l

0.47

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.28

0.24

3.5

2.4

—

(3035933) Granulocytes/100 leukocytes in Blood

143

1.19

0.23

1.1

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

483

0.91

0.22

1.1

1.0

1.84

0.65

u/ml

0.41

148

(3027008) Opiates [Presence] in Urine

151

1440

1.05

0.22

2.6

2.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.22

0.22

2.2

1.4

2.74

0.93

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.22

0.22

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

136

1429

0.95

0.22

5.2

3.1

27.04

29.28

mg/l

0.32

876

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

178

0.84

0.22

1.3

3.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.21

0.0

2.3

—

12.98

—

(3044290) Cell count panel - Cerebral spinal fluid

135

1285

1.05

0.21

1.4

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

188

0.85

0.21

1.4

1.2

17.17

17.83

—

(3028300) Cannabinoids [Presence] in Urine

151

1443

1.05

0.20

2.6

2.2

—

(3006270) Folate [Moles/volume] in Blood

543

0.92

0.20

1.2

1.1

367.05

347.46

nmol/l

0.24

439

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

316

1.11

0.20

5.9

6.6

—

(3027944) Amphetamines [Presence] in Urine

147

1405

1.05

0.20

2.6

2.2

—

(3001729) Color of Synovial fluid

1.22

0.20

2.0

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

149

1427

1.04

0.19

2.6

2.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

767

0.94

0.19

1.1

1.49

1.29

u/ml

0.12

342

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

443

1.08

0.19

4.4

5.1

27.24

77.57

u/ml

1.84

141

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

204

1.13

0.18

1.4

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

824

1.06

0.17

1.8

1.9

22.30

30.59

mg/l

0.69

206

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.15

0.17

1.6

2.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

176

1.14

0.17

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.11

0.17

1.4

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.71

0.16

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

895

0.95

0.16

1.2

1.1

0.43

1.68

u/ml

4.67

478

(37021550) Renin [Units/volume] in Plasma --upright

139

1.15

0.16

1.5

1.3

184.22

64.32

mu/l

0.68

104

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.10

0.15

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

144

1389

1.04

0.15

1.4

1.5

52.86

17.46

e6/l

0.44

109

1053

(3006462) Nitrate [Presence] in Urine

296

0.91

0.14

2.1

3.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

144

1392

1.03

0.14

1.5

786.83

2807.02

e6/l

0.65

115

1110

(3011288) Drugs identified in Urine by Screen method

920

1.04

0.14

6.4

3.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.81

0.13

1.4

1.6

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

114

1.14

0.11

1.0

4.67

13.66

u/ml

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

328

1.07

0.11

1.7

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

229

0.92

0.10

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

587

0.95

0.10

1.1

5.04

3.69

u/ml

0.25

274

(3010726) Horse dander IgE Ab [Units/volume] in Serum

709

0.96

0.10

1.1

0.89

1.51

u/ml

0.71

355

(3045424) Erythrocytes [Presence] in Urine

108

1046

1.03

0.10

1.6

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.06

0.09

1.0

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

252

1.07

0.09

1.1

0.70

1.14

u/ml

0.46

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

282

1.06

0.08

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

664

0.96

0.08

3.3

2.9

36.34

26.71

mg/l

0.28

483

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

480

1.04

0.07

1.8

1.5

0.17

0.24

nmol/l

1.29

372

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

662

0.97

0.07

1.1

2.67

3.18

u/ml

0.24

289

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.80

0.07

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

143

1401

1.02

0.07

1.2

1.3

3.82

3.83

mmol/l

0.05

134

1322

(3014599) Egg white IgE Ab [Units/volume] in Serum

245

1.06

0.07

1.0

1.1

0.53

1.45

u/ml

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.06

0.07

1.1

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.05

0.07

1.6

2.0

16.69

18.04

umol/l

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

344

1.05

0.06

1.4

1.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

274

0.95

0.06

1.7

1.3

71.14

65.23

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

545

0.97

0.05

1.1

5.97

5.30

u/ml

0.06

217

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

170

1.06

0.04

3.6

3.2

—

(40762814) Titanium [Mass/volume] in Blood

141

1.06

0.03

2.6

2.2

3.02

3.61

ug/l

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

783

0.98

0.03

1.1

6.55

4.37

u/ml

0.52

403

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

169

0.95

0.03

2.6

3.8

9.01

7.57

mg/l

0.32

137

(3015076) Soybean IgE Ab [Units/volume] in Serum

221

1.04

0.03

1.0

1.1

0.41

4.48

u/ml

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

470

1.02

0.02

1.5

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

137

0.95

0.01

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

147

0.95

0.01

1.2

—

645.00

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

353

1.02

0.01

1.1

1.4

1.45

1.55

g/l

1.90

353

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

146

0.96

0.00

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

404

1.01

0.00

1.0

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

100

1.00

0.00

2.4

1.8

106.01

49.81

pmol/l

—

(3022689) Creatine [Moles/volume] in Urine

205

1.02

0.00

2.0

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

262

0.99

0.00

1.2

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

926

1.00

0.00

4.8

4.6

349.42

352.53

umol/l

0.07

764

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

147

1470

1.00

0.00

2.3

3.5

738.08

867.95

u/ml

0.12

131

1338

(40758292) HTLV I+II Ab panel - Serum

1.04

0.00

1.5

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

330

1.00

0.00

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1542.22

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

24.21

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.96

-0.00

1.0

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.91

-0.00

1.3

1.5

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3007916) DNA double strand Ab [Titer] in Serum

0.95

-0.00

1.0

1.2

—

54.38

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.89

-0.00

1.3

1.9

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.58

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.96

-0.00

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.02

-0.00

1.7

2.1

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.97

-0.00

1.2

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_CARDMYO and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_CARDMYO	2.494 [2.27, 2.74]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.212

During the follow-up period (1.1.1998 — 31.12.2019), 4442 out of 13050 females with I9_CARDMYO died.

Males

Parameter	HR [95% CI]	p-value
I9_CARDMYO	2.801 [2.55, 3.08]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 10866 out of 26799 males with I9_CARDMYO died.

Mortality risk

Mortality risk for people of age

years, who have I9_CARDMYO.

N-year risk	Females	Males
1	0.299%	0.505%
5	1.513%	2.841%
10	3.438%	7.203%
15	6.214%	13.511%
20	11.01%	22.488%

Relationships between endpoints

↥

Index endpoint: I9_CARDMYO – Cardiomyopathy

GWS hits: 23

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cardiomyopathy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints